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ABSTRACT
Methylmercury (MeHg) is a ubiquitous environmental toxin. Exposure to MeHg
in humans occurs primarily through the consumption of contaminated seafood. MeHg has
been shown to act most strongly during neural development. Epidemiological data on the
effect MeHg exposure through seafood has on children and fetuses is conflicted, with
large cohort studies showing both presence and absence of MeHg-induced deficits in
achieving developmental milestones. Because of this uncertainty in the literature it is
important that we come to understand the mechanisms of MeHg toxicity so that we might
advise the public more accurately on the risks of MeHg exposure.
Research into the mechanisms of MeHg toxicity has found a number of cellular
and molecular effects including disruptions of microtubule formation, Ca2+ homeostasis,
and glutamate signaling. However, none of these effects of MeHg fully explains its
neurodevelopmental specificity. Previous work in Drosophila neural-derived cell lines
has shown that MeHg causes upregulation of the canonical Notch response gene
E(spl)mδ. The Notch pathway is crucial to neural development and perturbation of a
Notch target may explain the developmental specificity of MeHg. In this dissertation I
describe experiments I performed to test the hypothesis that the observed upregulation of
E(spl)mδ plays an important role in MeHg toxicity in Drosophila.
I first describe experimental evidence that E(spl)mδ is upregulated by MeHg
treatment in vivo in Drosophila embryos in addition to cells, as has previously been
shown. By contrasting the effects of the toxic inorganic mercurial HgCl2 with MeHg I
show that the E(spl)mδ expression response to MeHg is not simply a stress response and
is a likely specific activity of MeHg. I also show that the effect of MeHg on E(spl)mδ
expression is not simply due to a developmental delay induced by the toxin.
I also identify two neural phenotypes of MeHg toxicity in Drosophila embryos, in
the outgrowth of the intersegmental and segmental motor nerves. Genetic manipulation
causing overactivity of the Notch pathway in neurons can mimic these phenotypes.
However, induced expression of E(spl)mδ in neurons does not cause a failure of motor
nerve outgrowth. Upon further examination I demonstrate that endogenous expression of
E(spl)mδ occurs in the muscle. Induced E(spl)mδ expression in the muscle causes a
segmental nerve phenotype similar to MeHg treatment, indicating a role for E(spl)mδ in
MeHg toxicity in this system. MeHg treatment and E(spl)mδ overexpression in the
muscle causes a failure of normal muscle development. Yet, this gross developmental
abnormality only partially explains the observed motor nerve phenotype. E(spl)mδ is
unique among the E(spl) genes in its ability to cause these muscle and motor nerve
phenotypes as shown by contrasting genetic manipulation of the closely related E(spl)mγ.
Overall my findings support the hypothesis that MeHg toxicity in Drosophila is
mediated in part by E(spl)mδ. They also suggest that E(spl)mδ plays an important role in
the formation of the muscle during embryonic development, contributing to the literature
describing disparate functions for E(spl) genes despite structural similarities. Finally, my
findings suggest that MeHg may be able to impact neural development through toxicity
in supporting tissues rather than neurons themselves. This final finding has implications
for the study of MeHg toxicity in humans, and is supported by previous findings that
describe a role of glia in modulating MeHg neurotoxicity.
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CHAPTER 1: LITERATURE REVIEW
1.1: Introduction
Methylmercury (MeHg) is a ubiquitous environmental contaminant with well
known neurotoxic effects in humans. Acute and chronic high dose exposures due to
industrial or agricultural accidents have revealed that MeHg exposure in adults causes a
diffuse central neuropathy leading to mental, sensory, and motor deficits. The developing
central nervous system has proven even more sensitive to MeHg toxicity; children
exposed in utero to MeHg in doses that showed subtle signs in the mother have been born
with profound neurological deficits including severe mental retardation, seizures,
cerebellar ataxia, and sensory deficit. It is hypothesized that even low dose exposure to
MeHg in utero due to maternal fish consumption can cause subtle developmental deficits,
due to the increased sensitivity of the fetal system to MeHg. Because of this the cellular
and molecular mechanisms of MeHg toxicity during development are the subjects of
intense scrutiny. It has been shown in vitro in cell lines derived from the model
organisms Drosophila melanogaster and Mus musculus that the traditional Notch targets
in the Enhancer of Split [E(spl)] complex are upregulated after treatment with MeHg
(Tamm et al., 2008). Since the Notch pathway is crucial to cell-fate determination during
development this perturbation of the E(spl) complex may be a core underlying
mechanism in the developmental neurotoxicity of MeHg. This work investigates the
effects of MeHg on neural development and interactions with the Notch pathway in vivo
using the Drosophila embryo model.
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1.2: Methylmercury
Pathology and epidemiology of methylmercury poisoning
Much of the information available on the pathology of MeHg poisoning stems
from two incidents of accidental mass poisoning of a population. During the 1940-1960’s
the Chisso Corporation produced MeHg as a byproduct of acetaldehyde synethesis
(Ekino et al., 2007). They released the MeHg in chemical waste dumped into rivers
flowing into Minamata Bay, a source of dietary fish and shellfish for the inhabitants of
the Minamata region of Japan (Ekino et al., 2007). Ingestion of the MeHg contaminated
seafood caused acute toxicity in the population (Ekino et al., 2007). Continued exposure
to MeHg released into Minamata Bay and the Shiranui Sea as recently as 1968 has
caused chronic toxicity (Ekino et al., 2007). Exposure in utero to concentrations of MeHg
causing only mild toxicity in the mothers has had profound effects on the child,
indicating that the developing nervous system is particularly vulnerable (Ekino et al.,
2007). In 1956 MeHg poisoning due to contamination of the Minamata Bay was
officially recognized and the clinical manifestation of MeHg poisoning was named
Minamata disease (MD) (Ekino et al., 2007).
The second mass contamination of a population with MeHg occurred in the
1970’s in Iraq. Seed grain given as agricultural aid was treated with MeHg as an
antifungal (Myers and Davidson, 2000). Consumption of this grain caused acute
poisoning in the population (Myers and Davidson, 2000). Because the source of the
poisoning was quickly identified and consumption ceased, exposure was in a large bolus
dose, opposed to the Minamata event, in which exposure was to chronic, relatively low
doses (Myers and Davidson, 2000). This quick recognition of the MeHg exposure also
2

allowed immediate study of the results, and reinforced the data indicating MeHg acted
most potently on the developing nervous system (Myers and Davidson, 2000).
MD is often classified into three subgroups: acute, chronic, and fetal. Acute MD
is found in adults who are exposed to large doses of MeHg. Postmortem analysis of
affected individuals indicates diffuse cortical and cerebellar neuropathy (Taber and
Hurley, 2008). This results in sensory, motor, and psychiatric deficits. The visual field
shows bilateral concentric constriction (Ekino et al., 2007). There is a deficit in speech
discrimination (Ekino et al., 2007). Olfaction and gustation show subjective changes
(Ekino et al., 2007). There is loss of sensitivity and two point discrimination in the distal
extremities (Ekino et al., 2007; Taber and Hurley, 2008). Cerebellar ataxia is common
(Ekino et al., 2007; Taber and Hurley, 2008). Changes in personality including lack of
volition and apathy are nearly ubiquitous (Ekino et al., 2007; Taber and Hurley, 2008).
Individuals suffering from chronic MD show similar deficits. A stocking and
glove pattern loss of sensation in the distal extremities was thought to indicate a
peripheral neuropathy. Further research, however, has shown that affected individuals
show no reduction in tendon reflexes and have unaltered peripheral conduction velocities,
indicating a central neuropathy (Ekino et al., 2007). Cerebellar ataxia has been shown
during early exposure to MeHg, but improves over time; chronic MD patients still show
deficits in movement and posture, however, due to sensory deficits resulting in sensory
ataxia (Ekino et al., 2007). Visual and auditory deficits have also been reported in chronic
MD patients (Ekino et al., 2007).
The most severe form of MD affects individuals exposed during development in
utero. In fetal MD individuals present with mental retardation, epileptic seizures, and
3

difficulty with most coordinated or involuntary motor tasks including chewing,
swallowing, speaking, and walking (Ekino et al., 2007; Taber and Hurley, 2008). Severe
cases result in akinetic mutism (Ekino et al., 2007; Taber and Hurley, 2008).
Because of the sensitivity of the developing nervous system to MeHg there has
been much concern about the effects of low doses of MeHg on children and fetuses.
Mercury can be found in many large bodies of water due to contamination from natural
and anthropogenic sources (Myers and Davidson, 2000; Clarkson et al., 2003). Aquatic
bacteria can turn elemental mercury into MeHg, which concentrates in large predatory
fish due to bioamplification. Fish and other seafood makes up a significant portion of the
diet of many populations, and through it they are exposed to MeHg (Myers and
Davidson, 2000; Clarkson et al., 2003). Several epidemiological studies have attempted
to identify effects of subacute dietary MeHg in developing individuals. Two studies stand
out because of their large sample sizes and methodological rigor: the Faroe Islands and
Seychelles Islands studies (Myers and Davidson, 2000).
The Faroes population is exposed to MeHg primarily through the consumption of
pilot whale blubber (Myers and Davidson, 2000; Castoldi et al., 2008a; Rice, 2008; Taber
and Hurley, 2008). In the study of this population MeHg was associated positively with
neurodevelopmental milestones in the first year after birth. This can be explained by an
association between breastfeeding and MeHg exposure during that timeframe (Grandjean
et al., 1995; Myers and Davidson, 2000; Castoldi et al., 2008a; Rice, 2008). At 7 years of
age, though, increased MeHg exposure prenatally (as measured by cord blood
concentrations) correlated with decreased performance on tests associated with memory,
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learning, and attention (Grandjean et al., 1997; Myers and Davidson, 2000; Castoldi et
al., 2008a; Rice, 2008).
The Seychelles Islands population is exposed to MeHg via deep sea and reef fish
(Myers and Davidson, 2000; Castoldi et al., 2008a; Rice, 2008; Taber and Hurley, 2008;
Myers et al., 2009). In the study of this population no negative effects were observed
from increased exposure to MeHg, either pre or postnatal. In fact, there were beneficial
effects shown to correlate with the amount of fish consumed (Davidson et al., 1995;
Myers et al., 1995; Myers and Davidson, 2000; Castoldi et al., 2008a; Rice, 2008; Taber
and Hurley, 2008; Myers et al., 2009).
The discordance found between the Faroe and Seychelles island studies has been
the topic of much debate. Many factors might have contributed to their disparate results.
One of the primary differences is the source of the MeHg. Pilot whale blubber is eaten
infrequently on the Faroes, but has a higher concentration of MeHg than fish. It also
contains other toxic contaminants such as polychlorinated biphenyls (Myers and
Davidson, 2000; Castoldi et al., 2008a; Rice, 2008; Taber and Hurley, 2008). The fish
eaten in the Seychelles contains omega-3 fatty acids and selenium, factors that may be
beneficial to neurodevelopment, and as such oppose the effects of MeHg (Myers and
Davidson, 2000; Castoldi et al., 2008a; Rice, 2008; Taber and Hurley, 2008). There are
also some methodological differences, such as a failure to correct for socioeconomic
effects in the Faroes study (Rice, 2008). Because of the opposing findings of the studies it
is still uncertain what risks the consumption of seafood might pose for fetuses and
children. Future studies may be aided by the use of neurophysiological metrics rather
than the neuropsychological tests that have predominated thus far. Patients with MD
5

show alterations in heart rate variability (HRV) indicating parasympathetic hypoactivity
and changes in the latency of brainstem auditory evoked potentials (BAEP) correlating
with MeHg exposure (Murata et al., 2007). These physiological tests will allow for data
that is completely objective and should be comparable across cultures (Murata et al.,
2007).
Animal models also allow the study of MeHg toxicity without the confounding
effect of diet or culture. Studies on non-human primates have shown similar effects to
those in humans, excepting only a relative sparing of the cerebellum in monkeys and
ambiguous results on cognitive development (Castoldi et al., 2008b). Rodent models also
show similar effects to humans, but must be used with care as the timeframe of
neurodevelopment is quite different than humans, with the third trimester in humans
roughly corresponding to the first 10 postnatal days in rats (Castoldi et al., 2008b).
Despite differences these animal models will continue to be useful for elucidating the
effects of MeHg toxicity, since every variable can be more closely controlled and
measured.

Methylmercury Biochemistry and Transport
Human exposure to MeHg occurs primarily through contaminated fish and other
seafood. In fish MeHg is most commonly found bound to the amino acid cysteine as
MeHg-cysteinate (Harris et al., 2003). This compound consists of the MeHg bound to the
thiol group of cysteine. MeHg shows a high affinity for thiols, and can rapidly exchange
between thiols in solution, allowing it to jump from protein to protein, binding to their
cysteine residues (LoPachin and Barber, 2006; Asaduzzaman et al., 2010). While MeHg
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is known to bind to DNA the affinity of MeHg for DNA is much lower than that for
thiols and no genotoxic effects of MeHg have been observed (Maki and Ott, 1981; Li et
al., 2006; Carmona et al., 2008). It has been shown in vitro that MeHg-L-cysteinate
crosses the plasma membranes of cells in a temperature sensitive process, indicating a
protein transporter (Heggland et al., 2009). MeHg-chloride (MeHgCl), however, crosses
the plasma membrane in a temperature insensitive process, implying passive diffusion
(Heggland et al., 2009). In MeHgCl the mercury-chloride bond is very strong and does
not spontaneously dissociate in aqueous solution, however the strong affinity of MeHg
for thiol groups allows rapid production of MeHg-cysteinate from MeHgCl upon addition
of cysteine (Harris et al., 2003; Heggland et al., 2009; Asaduzzaman et al., 2010).
Once consumed MeHg is taken up in the gut by L-type large amino acid
transporters (Clarkson and Magos, 2006; Hoffmeyer et al., 2006; Clarkson et al., 2007;
Heggland et al., 2009). MeHg then enters the blood where it accumulates in red blood
cells and binds to cysteine residues on hemoglobin and glutathione (Doi and Tagawa,
1983). The MeHg then distributes to tissues throughout the body, leaving the red blood
cells with glutathione and entering other tissues after binding free cysteine (Doi and
Tagawa, 1983). In this manner it can cross the placental and blood-brain barrier
(Clarkson and Magos, 2006; Clarkson et al., 2007). Some MeHg is excreted with
glutathione in the bile, but breakdown of the glutathione releases MeHg-cysteine, which
can be reabsorbed, forming an enterohepatic cycle (Clarkson and Magos, 2006; Clarkson
et al., 2007). A small amount of MeHg in the gut is converted to inorganic mercury by
intestinal flora, which is then excreted (Clarkson and Magos, 2006; Clarkson et al.,
2007).
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Many early studies investigated the distribution of MeHg in the various cell
compartments of animals fed or injected with radiolabeled MeHg. Subcellular
fractionation of tissues including brain, liver, and kidney showed MeHg accumulation in
the lysosome/peroxisome, microsome, and mitochondrial fractions (Norseth and
Brendeford, 1971; Syversen, 1974; Mehra and Choi, 1981). Each of the studies also saw
MeHg accumulation in the nuclear fraction, though contamination of this fraction by
other organelles cast doubt on whether the nuclei themselves contain MeHg (Norseth and
Brendeford, 1971; Syversen, 1974; Mehra and Choi, 1981). An investigation using
microautoradiographic imaging to determine MeHg distribution in the liver found
evidence for MeHg in nuclei, reinforcing the finding from cell fractionation (Sakai,
1975). It is thus possible that MeHg has effects in any cell compartment; specifically, its
effects on E(spl) gene expression may be due to direct interaction with nuclear proteins.

Cellular and molecular effects of methylmercury
The mechanisms of MeHg toxicity have not yet been fully elucidated. There has
been a great effort to characterize the cellular and molecular effects of MeHg in order to
begin understanding these mechanisms of toxicity. An important first step has been
understanding the deposition and elimination of MeHg in the body.
MeHg is readily absorbed in the gastrointestinal tracts with about 95% of the
MeHg consumed being absorbed (Clarkson and Magos, 2006). Within three days most of
the MeHg distributes out of the blood into other tissues (Clarkson and Magos, 2006).
Brain tissue shows five times more MeHg than the blood and scalp hair shows MeHg at
250 times the concentration found in blood (Clarkson and Magos, 2006).
8

Recent research has revealed MeHg causes disruption of microtubule formation.
By binding to tubulin MeHg has been shown to inhibit polymerization and depolymerize
assembled tubules (Castoldi et al., 2001; do Nascimento et al., 2008). This has been
observed in many cell lines, including human fibroblasts, neuroblastoma, and glioma
cells (Castoldi et al., 2001; do Nascimento et al., 2008). Microtubule formation is
critically important to many processes, not the least of which is neural development. This
disruption of microtubules is consistent with the effects of MeHg on the brains of infants
exposed in utero in Iraq; they showed a reduction of brain size and disordering of brain
arrangement which could have been caused by lack of microtubule formation (Castoldi et
al., 2001; do Nascimento et al., 2008).
MeHg has also been shown to disrupt calcium homeostasis. Calcium ions (Ca2+)
have been shown to play a role in central nervous cell death. At low concentrations
MeHg has been shown to cause increased intracellular Ca2+ concentrations in cerebellar
cell culture (Castoldi et al., 2001; do Nascimento et al., 2008). Ca2+ channel blockers and
the Ca2+ chelator BAPTA protected these cells from MeHg-induced cell death (Castoldi
et al., 2001; do Nascimento et al., 2008). In vivo administration of voltage-dependant
Ca2+ channel blockers protected rats from neurological disorders due to MeHg treatment
(Castoldi et al., 2001; do Nascimento et al., 2008).
Much work has focused on the effects of MeHg on the glutamatergic system and
oxidative stress. MeHg has been shown to accumulate in astrocytes where it inhibits
uptake and stimulates release of the excitatory neurotransmitter glutamate (Castoldi et al.,
2001; Aschner et al., 2007; do Nascimento et al., 2008). This increased concentration of
glutamate in the extracellular space can cause excitotoxicity in neurons. Glutamate
9

activates its receptors, which cause an increase in Na+ influx, which leads to release of
Ca2+ from intracellular stores (Castoldi et al., 2001; Aschner et al., 2007; do Nascimento
et al., 2008). This in turn leads to the generation of reactive oxygen species (ROS), which
accumulate and kill the neurons (Castoldi et al., 2001; Aschner et al., 2007; do
Nascimento et al., 2008). The central role of glutamate accumulation in MeHg toxicity
has been reinforced by experiments which show that cotreatment with N-methyl-Daspartate (NMDA) receptor antagonists can attenuate the toxic effects of MeHg in
cerebral neuron culture (Castoldi et al., 2001; Aschner et al., 2007; do Nascimento et al.,
2008). These findings have led some researchers to postulate that the neurotoxic effects
of MeHg are simply repercussions of its effects in astrocytes. Further work highlighting
the importance of oxidative stress in MeHg toxicity involves the Nrf2/Keap1 complex. In
this complex Keap1 binds to Nrf2, keeping it inactive in the cytosol; when Keap1 is
modified by a perturbation of the oxidation state of the cell it releases Nrf2 which enters
the nucleus and binds to antioxidant response elements (AREs) that regulate expression
of traditional oxidative stress protectors, such as glutamate cysteine ligase (GCL), the rate
limiting enzyme in the production of glutathione (Toyama et al., 2007). In human
neuroblastoma SH-SY5Y cells treatment with MeHg has been shown to dissociate
Nrf2/Keap1, allowing activation of AREs (Toyama et al., 2007).
Other genetic and epigenetic effects have also been observed in response to MeHg
exposure. Many metals, including cadmium, arsenic, nickel, and chromium have been
shown to influence epigenetic changes. The common cause has been hypothesized to be
DNA damage caused by oxidative stress (Baccarelli and Bollati, 2009). Perinatal MeHg
exposure has been implicated in the epigenetic alteration of brain derived neurotrophic
10

factor (BDNF) regulation in the mouse hippocampus. Three major changes were
observed in promoter IV of the BDNF gene: an increase in histone H3-K27
trimethylation, an increase in DNA methylation, and a decrease in histone H3 acetylation.
Each of these is consistent with the observed decrease in BDNF mRNA levels
(Onishchenko et al., 2008).
In Drosophila early work showed that MeHg was toxic at much lower doses than
methoxyethyl mercuric compounds (Sorsa and Pfeifer, 1973). It was also found that
MeHg altered the puffing pattern of the prepupal salivary chromosomes, a measure
indicating changes in gene regulation due to MeHg exposure (Sorsa and Pfeifer, 1973).
MeHg has shown no evidence of genotoxicity in Drosophila, though, likely due to
lethality by other mechanisms at doses too low to cause genotoxic damage (Carmona et
al., 2008).
MeHg has also been shown to cause upregulation of genes in the Notch receptor
pathway, specifically genes of the E(spl) complex, in Drosophila (Bland and Rand,
2006). This effect has been shown to occur independent of the Notch receptor itself and
its coactivator Suppressor of Hairless Su(H) (Rand et al., 2008). Because of the key role
Notch and its targets play in the development of the nervous system, specifically in cellfate determination, this effect of MeHg on the E(spl) complex genes may prove crucial to
the understanding of the neurodevelopmental toxicity of MeHg. To further investigate
this effect a detailed understanding of the Notch pathway is important.

11

1.3: Notch pathway
The Notch cell-to-cell signaling pathway is involved in cell fate determination in
many tissues. It is crucial to neural development, and interference with it leads to serious
failures in neural differentiation or migration, akin to those seen in fetal MD.
Notch receptor structure and function has been largely elucidated in the
Drosophila model. Notch is classified as a neurogenic gene because mutations in it cause
an increased number of neuroblasts to form in the neurectoderm, a region in the ventral
part of the embryo of Drosophila melanogaster (Subiza et al., 1987; Campos-Ortega and
Knust, 1990). Other neurogenic genes include Delta and the E(spl) complex, which was
originally thought to be a single gene (Subiza et al., 1987; Campos-Ortega and Knust,
1990). Early work established a link between Notch and E(spl), correctly identifying
E(spl) as a downstream target of Notch (Subiza et al., 1987; Campos-Ortega and Knust,
1990). It was soon recognized that E(spl) was not a single gene with a large neurogenic
effect when mutated, but a complex of several genes which each produced a subtle
phenotype (Preiss et al., 1988). 13 genes have been identified in the E(spl) complex: mδ,
mγ, mβ, mα, m1, m2, m3, m4, m5, m6, m7, m8, and groucho (Fig. 1-1) (Wurmbach et al.,
1999) (Lai et al., 2000). Of these, seven (mδ, mγ, mβ, m3, m5, m7, m8) code for basic
helix-loop-helix (bHLH) transcriptional repressors, four (mα, m2, m4, m6) code for
Bearded family transcription factors, one (groucho) codes for a transcriptional
corepressor, and one (m1) codes for a putative protease inhibitor (Wurmbach et al., 1999;
Lai et al., 2000).
The Notch pathway is involved primarily in lateral inhibition during cell fate
determination during development. One of the most widely studied examples is
12

development of the Drosophila peripheral nervous system. In this system sensory organ
precursors (SOPs) begin as groups of equipotent cells. The center cell expresses Delta, a
ligand of Notch, which causes Notch activation in the surrounding cells, leading to a
signal cascade that upregulates expression of E(spl) complex genes (Portin, 2002). Early
evidence for the regulation of E(spl) by Notch was the distinct pattern of E(spl)
expression in the epidermal cells surrounding neuroblasts during nervous system
development in Drosophila, which corresponded to known patterns of Notch activation
(Jennings et al., 1994).
The Notch pathway has been shown to have a role in the development of many
tissue types. The role of Notch in the developing nervous system is well studied. During
development of the central nervous system in Drosophila embryos Notch causes lateral
inhibition in a population of equipotent cells, allowing only some to differentiate into
neuroblasts while the rest become epidermal cells (Portin, 2002). In the peripheral
nervous system during embryo development Notch signaling plays a similar role,
allowing some cells to become epidermal instead of nervous. Notch signaling is crucial to
the proper formation of the sensory bristles during adult development (Portin, 2002).
Notch is also involved in the development of the wing; in fact, the name Notch derives
from the notched appearance of the wing in certain mutant strains. Notch signaling is
involved in the development of wing veins; its ligand Delta is expressed in the region to
become a vein, and Notch is expressed in the surrounding area, causing it to remain
undifferentiated (Huppert et al., 1997). There is preliminary evidence that indicates Notch
plays a role in the development of the Drosophila gut. The E(spl) gene mβ shows
expression throughout the developing larval midgut that drastically increases at
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prepuparium (Maeder et al., 2009). Other E(spl) genes, such as mγ and mα have also
been shown to be expressed in the developing midgut (Maeder et al., 2009). During the
embryonic development of the muscles Notch has been shown to be involved in the
differentiation of muscle progenitors and the maintenance of this cell population until
muscle fusion, in which muscle founder cells orchestrate the formation of the final
muscle pattern (Fuerstenberg and Giniger, 1998; Maqbool and Jagla, 2007; Vasyutina et
al., 2007; Tixier et al., 2010). Notch has been shown to also have a role in oogenesis and
development of the appendages and Malpigian tubules of Drosophila (Portin, 2002).
Effects of Notch on neurite outgrowth have also been well-established, and will be
addressed later.
It has been shown that various E(spl) genes perform certain roles better than
others. mβ has been shown to be best at wing vein suppression and shows the most
extensive expression in the gut (Ligoxygakis et al., 1999; Maeder et al., 2009), mδ
performs best at lateral inhibition in the eye (Ligoxygakis et al., 1998), m7 and m8 have
been shown to suppress bristle formation best (Ligoxygakis et al., 1999), and mγ has been
shown to serve best at activating the gene cut during wing formation (Ligoxygakis et al.,
1999). Even the lesser studied Bearded family E(spl) genes have been shown to have
specific effects; m6 overexpression causes increased bristle formation, but m2
overexpression causes lack of bristles (Lai et al., 2000). The various E(spl) genes also
express in different patterns. In the gut, for example, mβ dots the entire midgut while mγ
is only expressed in two specific bands (Maeder et al., 2009). This differential expression
is due to differing sensitivities of the E(spl) genes to proneural genes and other spatially
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restricted factors (Nellesen et al., 1999; Wech et al., 1999; Cooper et al., 2000; Maeder et
al., 2007). The upstream enhancer regions of the E(spl) genes show patterns of Su(H) and
proneural binding sites that are specific to each gene. Paired Su(H) sites and Su(H) sites
paired with proneural sites are almost completely conserved among Drosophila species,
indicating their importance (Maeder et al., 2007). Recent work has shown that the
expression of m8 is heavily reliant on proneural proteins, but mγ shows little in vivo
reliance on proneural proteins for its expression (Cooper et al., 2000). So it has been
shown that the different E(spl) genes show distinct expression patterns and roles in Notch
signaling; despite this there is some overlap of function, though, since no tissue expresses
only one E(spl) gene and mutation of any one E(spl) shows little discernable phenotype
(Wech et al., 1999). In fact, studies of single nucleotide polymorphisms (SNPs) in wildcaught Drosophila melanogaster have shown that no significant association can be found
between bristle number and E(spl) SNPs; one might expect there to be an association
because of the important role of E(spl) in bristle development, but the fact that there isn’t
reinforces the finding that E(spl) genes have some redundancy (Macdonald et al., 2005).
While much of the data on the Notch pathway has been generated in the
Drosophila model its presence has also been verified in other systems. In the murine
system four homologues of Notch have been identified, Notch1-4 (Jarriault et al., 1998).
Homologues for the Notch ligands Delta and Serrate have also been found; Delta-like-1
and Delta-like-3 are murine homologues of Delta and Jagged-2 is the murine homologue
of Serrate (Jarriault et al., 1998). The Su(H) gene also has a murine homologue, named
RBP-J (Jarriault et al., 1998). The murine homologues of the E(spl) genes are the HES
family genes, with HES-1 being the most studied (Jarriault et al., 1998). Thus the entire
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Notch pathway has been identified in mice, and it works similarly to the Drosophila
homologue: Delta-like-1 has been shown to activate Notch-1, which binds to RBP-J and
enhances HES-1 expression (Jarriault et al., 1998). Because this pathway has proved to be
highly conserved between Drosophila and mammals it has been identified as a ripe target
for the study of toxicological effects; findings in Drosophila are likely to hold at least
partially true in mammals (Rand, 2009).

Notch signaling pathway overview
The molecular mechanisms of Notch signaling are well defined in Drosophila.
The process progresses from activation of the Notch receptor to a signaling cascade that
induces the ultimate effectors of the pathway, the E(spl) genes (Fig. 1-2). The E(spl)
proteins function in lateral inhibition during tissue development, restricting most
equipotent precursors from differentiating and allowing only the appropriate numbers of
cells to assume a differentiated fate.
Notch is a transmembrane receptor containing repeated elements of epidermal
growth factor (EGF) motifs (Portin, 2002). Two Notch ligands have been identified in
Drosophila, Delta and Serrate, which bind the EGF sites and cause Notch activation when
expressed on the surface of neighboring cells (Portin, 2002).
Once bound by a ligand the Notch extracellular domain is cleaved from the
transmembrane/intracellular domains by ADAM (a disintegrin and metalloprotease)
family proteases, such as Kuzbanian (Portin, 2002). After being cleaved from the
extracellular domain the transmembrane/intracellular fragment is cleaved again, releasing
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the intracellular fragment into the cytosol, in a process mediated by a Presenilin/γ–
secretase protein complex (Portin, 2002).
Once free the Notch intracellular domain localizes to the cell nucleus, where it
binds Su(H) proteins (Bailey and Posakony, 1995). This Notch binding allows the
disassociation of Su(H) from corepressors that cause it to act as a repressor of gene
transcription (Bray and Furriols, 2001). In this manner Notch may act as a permissive
activator of Su(H), allowing Su(H) to act on its own as a transcriptional enhancer; this is
thought to be the case in many Notch activity-dependent processes that do not rely on the
E(spl) complex, such as proneural enhancement (de Celis et al., 1996; Bray and Furriols,
2001). Notch can also act as an instructive activator of Su(H), recruiting cofactors and
facilitating the formation of a protein complex to activate Notch target genes; this is
thought to be the case in Notch-dependant activation of E(spl) gene expression (Bray and
Furriols, 2001).
Once bHLH E(spl) proteins have been produced they facilitate lateral inhibition
during cell differentiation (Jennings et al., 1999). By binding to DNA motifs that overlap
with binding sites for proneural proteins the bHLH E(spl) proteins directly oppose the
effects of the proneurals (Jennings et al., 1999). Since the proneurals are heavily involved
in differentiation of cells the effect of the bHLH E(spl) proteins is to stop cells from
differentiating due to proneural expression (Jennings et al., 1994). The roles of other
E(spl) proteins, those in the Bearded family, groucho, and the putative protease inhibitor
m1, are less well understood.
Thus in the peripheral nervous system of Drosophila melanogaster during
embryonic development the pathway acts as follows. Delta expressed in the center cells
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of equipotent groups of ectodermal lineage binds to Notch in the surrounding cells
(Portin, 2002). Notch is cleaved twice, once by an ADAM protease and a second time by
Presenilin, releasing the intracellular domain. The Notch intracellular domain enters the
nucleus where it binds Su(H) and recruits additional cofactors to enhance expression of
E(spl) genes (Bray and Furriols, 2001). The bHLH E(spl) proteins produced oppose the
effects of proneural proteins, which prevents the surrounding cells where Notch was
activated from becoming neuronal, while the center cell where Notch was not activated
differentiates into a neural precursor (Jennings et al., 1999).

Methylmercury and the Enhancer of Split locus
As early as 1973 it was noticed that MeHg has an effect on the genetics of
Drosophila melanogaster; treatment with MeHg was observed to alter the puffing pattern
of prepupal salivary chromosomes (Sorsa and Pfeifer, 1973). While this method certainly
does not have the power of modern techniques it does indicate the ability of MeHg to
affect the Drosophila genome. Recent studies have underscored the potential importance
of the gene regulatory effects of MeHg on its toxicity.
It has been shown that treatment of neural-derived Drosophila cell lines and
whole embryos with MeHg induces expression of genes in the E(spl) complex (Bland and
Rand, 2006; Rand et al., 2008). This expression was initially attributed to an increase in
Notch cleavage and thus presumed to increase signaling via the Notch intracellular
domain (Bland and Rand, 2006). This was supported when knockdown of Notch
expression using interfering RNA (RNAi) attenuated the response of the mγ gene to
MeHg treatment (Bland and Rand, 2006). Further work characterizing the E(spl)
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response to MeHg indicated an increase in gene expression in as little as three hours of
MeHg treatment (Rand et al., 2008). Looking at RNAi knockdown of Notch and Su(H) at
this time point revealed no effect of either on MeHg-induced mγ expression (Rand et al.,
2008). This conflicting data might indicate that Notch is involved in a secondary effect of
MeHg and that it does not play a role until after the initial three hour time point (Rand et
al., 2008). This is supported by the finding that the pattern of E(spl) gene expression
differs when induced acutely by MeHg versus Notch (Fig. 1-3) (Rand et al., 2008).
Treatment of cells with the calcium chelator ethylenediaminetetraacetic acid (EDTA)
causes cleavage of Notch expressed on the cell surface, releasing the intracellular domain
and stimulating the Notch pathway through endogenous Notch protein (Rand et al.,
2008). The effects on the E(spl) locus of treatment with MeHg were compared to
endogenous Notch activity stimulated with EDTA using quantitative real-time
polymerase chain reaction (qPCR). It was found that Notch primarily causes upregulation
of the E(spl) m3 and m7 genes with modest increases in m2, mγ, and mβ; importantly the
mδ gene shows very little upregulation due to endogenous Notch activity (Rand et al.,
2008). MeHg treatment caused upregulation primarily in the mδ and mγ genes, with little
upregulation of m3 (Rand et al., 2008). If MeHg was acting through Notch to cause its
upregulation of E(spl) genes, it would be expected that MeHg and EDTA treatments
would cause upregulation of the same genes. Because the mδ gene shows little expression
due to endogenous Notch activity but is highly upregulated due to MeHg treatment we
hypothesize it plays an important role in the neurotoxicity of MeHg.
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The effect of MeHg on E(spl) genes is not exclusive to Drosophila. Studies using
rat neural stem cells (NTCs) indicate that MeHg can inhibit NTC differentiation (Tamm
et al., 2008). This failure to differentiate was correlated with an increase in Notch activity
measured by increased cleavage of the Notch intracellular domain (Tamm et al., 2008).
Pretreatment with a Notch cleavage inhibitor reversed the repression of neuronal
differentiation due to MeHg treatment (Tamm et al., 2008). While these findings seem to
indicate that MeHg acts in a Notch dependant manner in rat NTCs it has yet to be seen if
a shorter time course of MeHg treatment relieves the Notch dependence, as has been
shown in Drosophila cell lines.

1.4: The Drosophila embryo
Drosophila melanogaster is an important model organism for the study of
developmental pathways and processes. It was in Drosophila that the Notch pathway was
first described, and Drosophila remains one of the best models in which to study Notch
signaling and other fundamental signaling pathways. There are three principle advantages
of the Drosophila model. First, it is well studied; the literature contains a wealth of
information on the genomics, genetics, transcriptomics, and proteomics that describe an
organism. Second, there exist a plethora of tools to utilize in Drosophila. Compared to
mammalian models it is easy to create transgenic animals; the gal4/UAS system allows
previously created transgenics to be combined into new driver/responder pairs, allowing
fast an efficient exploration of gene/tissue interactions (Fig. 1-4). Finally the Drosophila
itself is easy to utilize and maintain. Fast generation times and large populations allow for
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rapid advancement and quick replication of experiments. Ease of storage removes the
need for expensive animal facilities and staff.
Additionally, Drosophila are exceptionally well suited for evaluation of
developmental toxicity. The developmental timeline of the embryo is well-established
(Fig. 1-5). The size and abundance of embryos allows immunostaining of whole mounts
with large samples for each experiment. Exposure of the embryos is also simplified in
Drosophila as many toxins, such as MeHg, diffuse readily into embryos that have had the
chorion membrane removed (Fig. 1-6).

Motor Nerve Pattern and Guidance
The development and anatomy of motor nerves in the Drosophila embryo has
been well studied and is easily accessible using immunofluorescent staining of whole
mounted embryos, making it a good model of neurodevelopment. Each abdominal
hemisegment of the embryo has two major motor nerves that emerge from the ventral
nerve cord, the intersegmental nerve (ISN) and segmental nerve (SN) (Fig. 1-7). The ISN
has three branches, the ISNa, ISNb, and ISNd (Kaufmann et al., 1998; Sun et al., 2001).
ISNa projects dorsally to innervate muscles in the dorsal field, including the dorsal
oblique and dorsal acute muscles (Kaufmann et al., 1998; Sun et al., 2001). The ISNb/d
both terminate in the ventral muscle field and innervate muscles including the ventral
longitudinal group (Kaufmann et al., 1998; Sun et al., 2001). The SN has two major
branches, the SNa and SNc (Kaufmann et al., 1998; Sun et al., 2001). The SNa itself has
a characteristic branching pattern, innervating the lateral transverse muscles with its
upper branch and the segmental border muscle with its lower branch (Kaufmann et al.,
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1998; Sun et al., 2001). The SNc innervates ventral muscle groups (Kaufmann et al.,
1998; Sun et al., 2001).
Axon outgrowth in these motor nerves has been well studied. There is evidence
that pioneer neurons establish the path for other axons to follow, though there is
remarkable resilience to ablation of these pioneers (Lin et al., 1995; Sanchez-Soriano and
Prokop, 2005). Fasciculin II (FasII) is the major adhesive molecule that maintains
fasciculation in the nerve fiber; higher FasII expression levels in the pioneer neurons
have been shown to cause them to grow ahead of other contributing neurons, establishing
the path of the nerve (Sanchez-Soriano and Prokop, 2005). Specifically, FasII loss of
function in the ISN pioneers, the aCC and RP2 neurons, causes them to lose their ability
to influence nerve outgrowth (Sanchez-Soriano and Prokop, 2005). Increasing expression
of FasII in follower neurons causes them to exert increased influence on the direction of
nerve outgrowth (Sanchez-Soriano and Prokop, 2005).
The guidance cues for motor axon outgrowth have only recently been elucidated.
It has been shown that during outgrowth the motor nerves contact glia, sensory nerves,
and muscle cells expressing Sidestep (Side), a transmembrane immunoglobulin
superfamily protein, in a tightly controlled temporospatial pattern (Fig. 1-8) (Aberle,
2009b, a; Siebert et al., 2009). Each of these tissues expresses Side only while they are in
the immediate path of the motor nerves, turning off expression as the growth cone
contacts and then passes them (Aberle, 2009b, a; Siebert et al., 2009). In Side mutants
axons fail to defasciculate, indicating that Side acts in opposition to FasII to cause
branching of motor axons (Aberle, 2009b, a; Siebert et al., 2009). Similarly, perturbation
of the mesoderm can cause failures in defasciculation of the motor nerves (Landgraf et
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al., 1999a). Mesodermal expression of the active Notch intracellular domain causes
failure to develop muscle founder cells, which organize the fusion of muscle fibers
(Landgraf et al., 1999a). Without muscle fibers to express Side motor axons fail to
defasciculate (Landgraf et al., 1999a). The protein Beaten path Ia (Beat) has been shown
to be the receptor for Side signals (Aberle, 2009b, a; Siebert et al., 2009). Beat is
expressed on motor nerve growth cones and has been shown to interact with Side
(Aberle, 2009b, a; Siebert et al., 2009). Beat mutants show motor axon defasciculation
failure similar to Side mutants (Aberle, 2009b, a; Siebert et al., 2009). Additionally,
unlike wild type axons, Beat mutants fail to follow ectopic Side expression (Aberle,
2009b, a; Siebert et al., 2009). These data indicate that Side/Beat act as the primary
attractive cues guiding motor axon outgrowth in embryos.
If Side/Beat are the directors of motor axon outgrowth, actin assembly in the
growth cone is the driving force behind it (Kaufmann et al., 1998). Evidence indicates
that the Rho-family GTPases Dcdc42 and Drac1 play important roles in organization of
the actin cytoskeleton in response to guidance cues (Kaufmann et al., 1998). Neuronal
expression of dominantly activated versions of either Dcdc42 or Drac1 causes arrest of
motor nerve outgrowth consistent with a disruption of leading edge motility (Kaufmann
et al., 1998). Dominant negative expression of the two reveal differences in function,
however; Dcdc42 dominant negative expression causes some axons to fail to reach their
most distal targets, whereas Drac1 dominant negative expression causes changes in the
trajectory of the axons but no change in outgrowth (Kaufmann et al., 1998). Both of these
phenotypes can be mimicked pharmacologically utilizing cytochalasin D to block actin
assembly (Kaufmann et al., 1998).
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Other molecules have also been shown to play important roles in axon outgrowth,
though the mechanisms of their action are less well defined. Five receptor-linked protein
tyrosine phosphatases, DPTP10D, DLAR, DPTP69D, DPTP99A, and DPTP52F are
expressed in embryonic Drosophila axons (Desai et al., 1997; Schindelholz et al., 2001;
Sun et al., 2001). Mutation analysis of these proteins indicates that they interact in a
variety of cooperative, redundant, or competitive ways depending upon cellular context
to contribute to motor nerve outgrowth and guidance (Desai et al., 1997; Schindelholz et
al., 2001; Sun et al., 2001). Mutation of these phosphatases, both individually and in
combination, can cause a variety of phenotypes in motor nerves including axon stalling,
failure to synapse, failure to form branches, and formation of additional branches (Desai
et al., 1997; Schindelholz et al., 2001; Sun et al., 2001). What role in axon outgrowth
these phosphatases play during normal development is still a matter of speculation.
The Notch pathway has also been shown to play a role in motor axon outgrowth.
It has been shown that Notch and Delta expression during outgrowth are necessary for
development of the ISN (Giniger et al., 1993; Crowner et al., 2003). Experiments
utilizing flies expressing a temperature-sensitive Notch allele have shown that removal of
Notch during outgrowth of the ISNb causes the axons to bypass their normal pathway,
remaining adhered the ISNa rather than branching (Crowner et al., 2003). Data indicates
that during normal axon outgrowth Notch protein expressed on the axon growth cone
suppresses activity of the Abl tyrosine kinase in a noncanonical mechanism that does not
involve Su(H) or E(spl)s; as the Abl pathway normally causes adhesion of the axons this
suppression of Abl by Notch allows the ISNb to defasciculate from the ISNa (Crowner et
al., 2003). Research into the role of Notch signaling in growth of longitudinal axons
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across segments in the central nervous system have revealed similar Notch/Abl
interactions resulting in decreased adhesion of axons to the substratum they grow across,
allowing motility (Kuzina et al., 2011). Additional studies have shown that mutation of
the Notch pathway regulator Endonuclease GI (EndoGI) causes failure of motor axons to
innervate their appropriate muscle targets; this may indicate that EndoGI is active in the
Notch/Abl signaling described in other work (O'Keefe et al., 2010). In cultured
embryonic mouse neurons Notch has been shown to play the opposite role; increased
Notch activity in these cells causes decreased neurite outgrowth (Sestan et al., 1999). The
mechanisms for this decrease in outgrowth have not been elucidated. Combined these
data indicate a complex, context-dependent role for Notch in neurite outgrowth.

1.5: Summary and significance
MeHg is a potent environmental toxin that strongly influences neural
development. Though MeHg has been shown to impact a variety of cellular processes,
the mechanism of its neurodevelopmental specificity is not yet fully understood.
Experiments have shown that MeHg causes upregulation of canonical Notch-response
genes in the E(spl) complex. Because of the crucial role of the Notch pathway in neural
development the changes in Notch target expression elicited by MeHg may be an
important mediator of the neurodevelopmental specificity of MeHg.
In this dissertation I hypothesize that overexpression of the E(spl) gene mδ plays a
critical role in MeHg toxicity in Drosophila. To test this I will first establish that MeHg
treatment in vivo is capable of causing E(spl)mδ overexpression, as it is in cell lines. I
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will then identify a neural phenotype of MeHg treatment in Drosophila embryos and
show that I am able to replicate it using genetic manipulation of E(spl)mδ.
The findings of this dissertation will support a role for the Notch pathway target
E(spl)mδ in MeHg toxicity, suggesting there be further study of the impact of MeHg on
E(spl) homologues in mammals. Additionally, my work will show that impacts on muscle
development can mediate the effect of MeHg on neural development; supported by the
previous work showing a glial impact of MeHg toxicity in mammals this finding suggests
that the neurodevelopmental specificity of MeHg may not be due to direct impacts on
neurons but instead on supporting tissues. Overall this work suggests new avenues of
research to apply these findings toward a greater understanding of MeHg toxicity in
humans.
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1.6: Figures

Figure 1 - 1. Schematic of the Enhancer of Split complex.
Adapted from (Krejci and Bray, 2007)

27

Notch Signaling Pathway
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Figure 1 - 2. Schematic of the Notch signaling pathway.
Notch expressed on the cell receiving the signal binds its ligand, expressed on the cell sending the signal.
After ligand binding ADAMs cleave the extracellular domain of the Notch protein from the
transmembrane/intracellular domains. Presenilin then cleaves the intracellular domain from the
transmembrane domain. The free Notch intracellular domain enters the cell nucleus where it binds to
Suppressor of Hairless [Su(H)], allowing dissociation from corepressors. Notch then recruits coactivators
and the Notch/Su(H) complex drives expression of Notch targets, specifically the Enhancer of Split [E(spl)]
gene complex.
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Figure 1 - 3. Methylmercury and Notch signaling show different fingerprints of E(spl) upregulation.
In the Drosophila neural-derived cell line bg2-c6, following MeHg treatment or Notch cleavage through
treatment with EDTA the relative expression levels of E(spl) complex genes were assayed via qPCR. The
figure shows relative fold change over untreated controls normalized to the RP49 housekeeping gene.
Modified from (Rand et al., 2008).
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Figure 1 - 4. Schematic of the GAL4/UAS exogenous expression system in Drosophila.
The GAL4/UAS system is widely used in Drosophila to drive expression of genes of interest under the
control of a promoter of interest. Female flies carrying a construct in which a driver of interest drives
expression of the yeast transcription factor GAL4 are bred with males carring a construct in which the yeast
upstream activator sequence (UAS) drives expression of a gene of interest. In cells where GAL4 is
expressed it binds to the UAS and drives expression of the gene of interest.

30

Embryo
development

Neural
development

Stage

Time

1-5

0-2:50 h

cleavageblastoderm

6-7

2:50-3:10

gastrulation

8-11

3:10-7:20

germband elongation
neurogenesis

12-13

7:20-10:20

germband
retraction

sibling neuron cell fates
neuron migration

14-15

10:20-13:00

dorsal closure

neurite outgrowth/
glial migration

16-17

13:00-22:00

differentiation

neurite outgrowth/
glial migration

NB specification/
sibling neuron cell fates

Figure 1 - 5. Stages of Drosophila embryo development.
Anterior is left and dorsal is up. Neuroblasts (light purple, at stage 8-11). Ventral nerve cord (VNC) and
brain neurons (purple, at St. 12-17). Endoderm/midgut (red). Mesoderm (green). Foregut/Hindgut (Blue).
Adapted from (Weigmann et al., 2003).
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Figure 1 - 6. Methods for in vitro exposure of Drosophila embryos to toxins.
Embryos collected from adults laying on grape-agar plates are dechorionated in dilute bleach. Embryos are
then placed in baskets designed to optimize air exposure while being immersed in a solution containing the
toxin of interest. After a period of developmental exposure, embryos can then be processed for RNA
isolation or for fixation, staining and, imaging. Adapted from (Engel et al., 2012).
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Figure 1 - 7. Image and schematic of motor nerves in the embryo.
A) Immunostaining embryos with αFasII antibody reveals the motor nerves. The intersegmental nerve
(ISN) has three main branches, the ISNa (labeled ISN), the ISNb, and the ISNd. The segmental nerve (SN)
has two major branches, the SNa and SNc. The SNa itself has a characteristic branch near its terminal so it
can innervate both the lateral transverse muscles and segmental border muscle. B) An illustration of the
motor nerves and the muscles they innervate in one hemisegment, showing genes specifically expressed in
different neuron populations. Adapted from (Landgraf et al., 1999a).
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Figure 1 - 8. Temporospatial regulation of Sidestep guides motor axon pathfinding.
Guidepost cells in the direct path of the developing embryonic motor axon express Sidestep (Side), an
attractive cue. The axon growth cones express Beaten path Ia (Beat), the receptor for Side. It is the
carefully timed expression of Side in the cells the axon must next grow towards that guides motor nerve
pathfinding in Drosophila. Adapted from (Siebert et al., 2009).
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CHAPTER 2: THE EFFECTS OF METHYLMERCURY ON NOTCH
SIGNALING DURING EMBRYONIC NEURAL DEVELOPMENT IN
DROSOPHILA MELANOGASTER

Material from this chapter has been published in the following form:
Engel GL, Delwig A, Rand MD (2012) The effects of methylmercury on Notch signaling
during embryonic neural development in Drosophila melanogaster. Toxicol In Vitro.
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2.1: Abstract
Methylmercury (MeHg) is a ubiquitous toxicant that targets the developing fetal nervous
system.

MeHg interacts with the Notch signaling pathway, a highly-conserved

intercellular signaling mechanism required for normal development. Notch signaling is
conveyed by activation of the genes in the Enhancer of Split (E(spl)) locus in Drosophila.
We have previously shown that acute high doses of MeHg upregulate several E(spl)
genes in Drosophila neural-derived C6 cells. Furthermore, MeHg induction of E(spl) can
occur independent of the Notch receptor itself.

We now show that MeHg, unlike

inorganic mercury (HgCl2), preferentially upregulates E(spl)mδ and E(spl)mγ in
Drosophila C6 cells. This is distinct from Delta ligand-induced Notch signaling in which
no induction of E(spl)mδ is seen. MeHg is also seen to specifically upregulate E(spl)mδ
in Drosophila embryos where HgCl2 showed no such effect. Additionally, treatment of
embryos with MeHg caused a consistent failure in axonal outgrowth of the
intersegmental nerve (ISN). This ISN phenotype was partially replicated by genetic
activation of the Notch pathway, but was not replicated by increasing expression of
E(spl)mδ. These data suggest a role for Notch signaling and the E(spl)mδ target gene in
MeHg toxicity, however, the site of action for E(spl)mδ in this system remains to be
elucidated.

2.2: Introduction
Methylmercury (MeHg) is a ubiquitous environmental toxin that preferentially
targets the developing nervous system. Because of its apparent specificity for neural
tissue, signaling pathways in neural development may be important targets in MeHg
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toxicity. Several studies in both mammalian and invertebrate systems now support the
hypothesis that the Notch pathway is a potential target for MeHg. Notch is a fundamental
cell-cell signaling pathway that directs cell fate decisions during neurogenesis. Being first
elucidated in Drosophila, it is now well understood that signals through Notch receptors
cause activation of downstream effectors; those of the Enhancer of Split [E(spl)] gene
locus in flies and the Hairy/Enhancer of Split (HES) genes in mammals (de-la-Concha et
al., 1988; Preiss et al., 1988; Jarriault et al., 1998). The E(spl) locus in flies consists of 11
genes in a single 50kb locus. Seven of these E(spl) genes, E(spl)mδ, E(spl)mγ, E(spl)mβ,
E(spl)m3, E(spl)m5, E(spl)m7, and E(spl)m8, are basic helix-loop-helix transcriptional
repressors. While different E(spl) genes are known to be preferentially expressed in
various developing tissues, manipulations in Drosophila demonstrate that all the E(spl)
genes are capable of responding to Notch signals (Jennings et al., 1999; Nellesen et al.,
1999; Wech et al., 1999; Wurmbach et al., 1999). Signals at the level of the Notch
receptor are propagated by cleavage and activation by members of the ADAM family of
metalloproteases. The potential for MeHg to stimulate ADAM activity initially led to the
hypothesis that MeHg could ultimately induce Notch signals (Bland and Rand, 2006).
This was supported by evidence that E(spl)mγ and E(spl)mβ show a dose-dependent
increase in transcription with MeHg applied to Drosophila neural cells in culture (Bland
and Rand, 2006). In subsequent studies we have shown that stimulation of E(spl) genes
in Drosophila cells by MeHg can occur despite knockdown of Notch receptor expression
(Rand et al., 2008). These observations suggest MeHg can act through a more direct
mechanism, bypassing the receptor to stimulate transcription of Notch targets.
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In this study, using MeHg exposures to Drosophila C6 neural derived cells in
culture in addition to exposures of the whole animal at various developmental stages, we
confirm a specific action of MeHg toward the E(spl)mδ gene. We also demonstrate that
E(spl)mδ, in stark contrast to the other E(spl)s, is not responsive to Notch signals
propagated by its cognate ligand, Delta, in the C6 neural cell line, allowing us to
elucidate the MeHg specific action on this gene target. A specific effect of MeHg relative
to inorganic mercury (HgCl2) in E(spl)mδ activation is observed in C6 cells and in
embryos, however, mercury induction of E(spl)mδ was not seen at later developmental
stages. MeHg treated embryos exhibit an overt defect in formation of the intersegmental
nerve (ISN). Increasing Notch pathway activity in neurons by driving expression of the
Notch intracellular domain (NICD) under the control of the pan-neural elav promoter
causes a similar defect in ISN outgrowth, however driving expression of E(spl)mδ in
neurons did not elicit an ISN phenotype.
Our findings indicate that MeHg specifically effects E(spl)mδ in vitro and in vivo
during Drosophila embryogenesis. Our data shows specificity in gene activation by
MeHg compared to other stressors, such as HgCl2, highlighting the potential for E(spl)mδ
to mediate some MeHg-induced changes in developmental signaling in the embryo.
However, neuron-specific expression of E(spl)mδ did not replicate a characteristic ISN
MeHg phenotype, which could be partially replicated with neuron-specific Notch
activation. These results point to novel non-canonical Notch pathway mechanisms that
contribute to MeHg toxicity in the embryonic nervous system.
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2.3: Methods
Cell Culture:
Drosophila bg2-c6 cells (C6 cells), a neural cell line obtained from the
Drosophila Genomics Resource Center (Ui et al., 1994) were cultured in Shields and
Sang M3 medium with added bactopeptone and yeastolate (BPYE), supplemented with
bovine serum, insulin, and penicillin/streptomycin at 25°C in a humidified incubator.

Cell culture mercury treatments:
Stock solutions of methylmercury (MeHg chloride, Aldrich 442534) and mercury
chloride (HgCl2, Sigma-Aldrich 215465) were prepared in dimethyl sulfoxide (DMSO) at
50mM. Mercury treatments were made at concentration ranging from 0-100µM. DMSO
concentration was adjusted to be equivalent across control and mercury treatments and
never exceeded 0.1% DMSO. Cells were plated at 80% confluence in standard medium
and allowed to adhere and recover for one hour. They were then washed three times with
M3 medium lacking serum or antibiotics (M3-) and the medium was replaced with M3with added mercury or DMSO control. Cells were treated for three hours, after which the
medium was removed and cells were harvested for either RNA extraction with Trizol
reagent (Invitrogen) or viability assays were performed.

Cell viability assay:
Cell viability was determined by dual staining with calcein and ethidium using the
LIVE/DEAD Viability/Cytotoxicity Kit for mammals (Invitrogen) as per product
instructions. Briefly, cells were treated with various concentrations of MeHg or HgCl2 for
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3hr, then treated with 2µM calcein AM and ethidium homodimer and incubated for
30min. Cells were washed, then plated and counted for green and red cells. Breakdown of
calcein AM by esterases causes green fluorescence and marks living cells, while
disruption of cell membranes in death allows permeability to ethidium homodimer
causing nuclear red fluorescence. The ratio of green to red cells, normalized to control
cell treatments and treatments eliciting 100% cell death, were used to determine the
measure of cell viability. (n>150 cells per single treatment across seven concentrations).

Fly stocks and crosses:
Unless otherwise stated, fly stocks were maintained on standard cornmeal-yeastmolasses food at 25°C. Lines used include Canton S, elav-GAL4 (Bloomington
Drosophila Stock Center, #458), UAS-Notchintra (gift from Cedric Wesley, University of
Wisconsin Laboratory of Genetics), and UAS-E(spl)mδ (Bloomington Drosophila Stock
Center, #26677). Standard crosses were performed between virgin female Gal4 driver
lines and male UAS responder lines to generate F1 progeny to be tested.

Embryo mercury treatments:
Cages of adult flies were allowed to lay eggs on a grape agar plate with yeast
paste smeared on the center. (See Fig. 2-4) Unless stated otherwise the embryo collection
occurred over a two hour laying period. Embryos were then aged on the grape plates at
25°C; standard aging time was two hours. Embryos were dechorionated using a standard
protocol. Briefly, embryos were washed from the plate using tap water and a brush into a
nytex basket, then rinsed to remove yeast; baskets were transferred to 50% bleach (~3.8%
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sodium hypochlorite) for three minutes, then rinsed in tap water to remove bleach.
Embryos were transferred to separate nytex baskets for each treatment, which were in
turn placed into petri dishes containing phosphate buffered saline (PBS) with added
mercury or DMSO control. These dishes were covered to prevent evaporation and the
embryos were allowed to incubate for 16-18 hours or various times where indicated. A
schematic of this novel in vitro method to dose embryos with toxins can be found in
Figure 2-4.

Immunostaining:
Immunostaining was performed as previously described (Rand et al., 2009).
Treated embryos were fixed in 500 µL of a 50:50 mix of 8% paraformaldehyde in 0.1 M
PIPES, 2 mM EGTA, 1 mM MgSO4, pH 6.9 (PEM) with heptane by rocking for 25 min.
Vitelline membranes were subsequently removed by discarding the lower PEM layer and
adding 750 mL MeOH, then vortexing for 30 s. Settled embryos were collected, washed
and stored at -20C in methanol until staining. For immunostaining, embryos were
permeablized in phosphate buffered saline (PBS) with 1% BSA, 0.1% triton X-100
(PBT). Subsequent blocking, primary and secondary antibody incubations were done in
PBT with 5% each of donkey and goat serum. Primary antibodies used were: mouse antielav (9F8A9), mouse anti-notch (9C6), and rat anti-FasII (1D4) (Obtained from the
Developmental Studies Hybridoma Bank, Univ. of Iowa). Secondary antibodies used
were: Alexa488-conjugated goat anti-rat and Alexa555-conjugated goat anti-mouse
(Jackson ImmunoResearch). Embryos were visualized by fluorescence microscopy on a
Leitz Orthoplan 2 microscope equipped with a Spot One digital camera and associated
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acquisition software (MVI, Avon, MA). Images were assembled in Adobe Photoshop,
GIMP, and Microsoft PowerPoint.

RNA Extraction and quantitative PCR:
After mercury treatments, embryos were transferred with a paintbrush into
microcentrifuge tubes containing PBS supplemented with 0.1% Triton-X and 1% bovine
serum albumin (PBT). The PBT was removed with a pipette and replaced with Trizol
reagent (Invitrogen). Embryos were homogenized in Trizol and processed for RNA
isolation. RNA samples were treated with Turbo DNAse (Ambion) and reversed
transcribed using SSII reverse transcriptase (Invitrogen). RNA was subsequently
removed with RNAse H (USB). cDNA samples were assayed for gene expression via
qRT-PCR using SybrGreen dye (Bio-Rad). Data were normalized to the ribosomal
protein RP49 housekeeping gene and analyzed using the comparative Ct method (Livak
and Schmittgen, 2001). Primer sequences for E(spl)mδ, E(spl)mγ, E(spl)mβ, E(spl)m2,
E(spl)m3, E(spl)m7, Notch, and the RP49 control were taken from (Rand et al., 2008).
The

sequences

used

for

Hsp70Ab

TGAGAGTGATAAGAATGTTTCGAT

were

and

Forward:
Reverse:

AGTCTACAAAACATTAAATGACCAAGTT. For Hsp70Bc the sequences were
Forward:

ATCAGCAGGGAGCGGGAGCA

TCACTTTTAAAAACTTAAGCCGAAA.
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and

Reverse:

Larval and adult mercury treatments:
Embryos collected from an overnight laying in a population cage were transferred
to bottles of standard cornmeal-molasses food supplemented with 15 µM MeHg or
DMSO (control). Embryos were allowed to develop until they reached the late third instar
wandering stage (approximately 4 days). At this stage they were harvested and disrupted
for RNA isolation using an RNeasy mini kit (Qiagen).
Adult flies were cultured for three days on food containing concentrations of
MeHg up to 100µM. The flies were then frozen using liquid nitrogen and broken apart
using a vortexer. Heads were collected using a sieve and subsequently homogenized in
Trizol reagent. RNA transcript levels were assayed by qRT-PCR as described above.

2.4: Results
We have previously demonstrated an ability of MeHg to induce E(spl) gene
expression in cultured Drosophila C6 cells (Rand et al., 2008). In this previous study
EDTA was used as a proxy to invoke Notch signaling in C6 cells for comparative effects
on E(spl) expression. Since notable differences between EDTA-induced and MeHginduced E(spl) activation was observed, we wished to further validate these effects with
respect to Notch signaling. To examine Notch signaling explicitly we co-cultured the C6
cells on fixed preparations of cells expressing Delta, the endogenous ligand of the Notch
receptor, in a previously established assay in our laboratory (Delwig and Rand, 2008).
We then analyzed E(spl) expression exclusively in the Notch expressing cells via qRTPCR (Fig. 2-1). This treatment caused the greatest induction of E(spl)mβ and E(spl)m3
(>20-fold), and a nearly 15-fold induction of E(spl)mγ. In contrast, E(spl)mδ was not
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upregulated by Delta induced Notch signaling. Overall, Delta induced Notch signaling
under these conditions gives a similar pattern of E(spl) induction as was seen with EDTA
earlier (Rand et al., 2008) indicating this profile is representative of Notch signaling in
this cell line.
We next sought to compare MeHg effects with inorganic mercury to determine if
the E(spl) activation profile of MeHg is unique or shares properties with other mercurials.
We first determined levels of toxicity of MeHg and HgCl2 toward C6 cells. Cell viability
subsequent to MeHg and HgCl2 exposures was determined using dual calcein/ethidium
staining (Fig. 2-2). A dose dependent decrease in cell viability was observed with MeHg,
which proved more potent than HgCl2. MeHg exhibited an approximate 20% cell death
(80% viability) at 4µM and an approximate 50% reduction in viability at 20µM. HgCl2
proved weaker showing an approximate 20% reduced viability at 20µM and 50% reduced
viability with 100µM HgCl2. Similar results were obtained using alternative
determinations with Trypan Blue reagent (Data not shown).

These doses were

implemented in subsequent assays of acute exposure effects on E(spl) activation.
With MeHg treatment of C6 cells E(spl)mδ, E(spl)mγ, and E(spl)m7 showed the
greatest fold-induction (7 to 12-fold, Fig. 2-3) of six representative E(spl) genes spanning
the E(spl) locus. E(spl)mβ and E(spl)m3 showed less substantial increases (less than 4fold) with MeHg treatment, while E(spl)m2 approached a 6-fold induction. In contrast,
cells treated with HgCl2 showed less than 3-fold response in E(spl)mδ and E(spl)mγ, and
less than 5-fold induction in E(spl)m7 (Fig. 2-3). E(spl)m2 responded to HgCl2 treatment
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with a nearly 9-fold change with 100µM MeHg (Fig. 2-3). These data show a differential
response of individual genes in the E(spl) locus with MeHg versus HgCl2 exposure.
The apparent unique effect of MeHg on E(spl) gene expression in vitro prompted
us to investigate similar effects in vivo. We have previously established an ability to dose
Drosophila embryos with MeHg cultured in vitro (Rand et al., 2009). This methodology
is summarized in Figure 2-4. The method takes advantage of the unique property that fly
embryos denuded of their outer chorion layers of the eggshell are permeable to MeHg
and are also able to continue development suspended in a defined culture media (see
methods and Figure 2-4).

Using this technique we evaluated the dose-response of

embryos to MeHg by assaying gene expression using qRT-PCR and monitoring the
response of a ubiquitous stress response gene, Hsp70. The Hsp70 Bc gene showed a
robust increase in expression with increasing levels of MeHg, confirming the entry of the
MeHg in embryonic tissues (Fig. 2-5). In parallel we probed E(spl)mδ gene expression
which was seen to increase across all concentrations of MeHg. A more than seven-fold
increase in E(spl)mδ was seen at 20µM MeHg, which appeared to be sustained at 50µM
MeHg. From these data we chose to treat embryos with 50µM MeHg in subsequent
analyses to ensure we were above a threshold in effect.
To assess the level of specificity with which MeHg acts on embryonic tissues we
again compared E(spl) expression response to MeHg versus HgCl2 treatment (Fig. 2-6).
After MeHg, treatment (50µM) E(spl)mδ consistently showed greater than three-fold
upregulation in embryos across several trials. In contrast, none of the other E(spl) genes
assayed showed a response to MeHg in embryos treated in vitro. In addition, Notch
showed no change in expression in response to MeHg, indicating that increases in
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E(spl)mδ could not stem from increased receptor expression. An induction of two Hsp70
genes Hsp70Ab and Hsp70Bc was observed for MeHg, again confirming entry of the
toxicant into the embryos. Treatment of embryos with 1mM HgCl2 did not cause any
increase in E(spl) gene expression. In contrast, a modest decrease was seen in levels
across all the E(spl) genes and Notch after HgCl2 treatment. Upregulation of Hsp70 genes
after HgCl2 treatment indicated that the dose of HgCl2 used showed a similar degree of
entry and overall toxic insult to that of MeHg. These data indicate that MeHg acts
selectively on E(spl)mδ transcription in Drosophila embryos.
E(spl) gene expression is known to change over the course of embryogenesis
(Tweedie et al., 2009). Recent data from gene expression arrays performed within the
large scale ModEncode project (Tweedie et al., 2009) and publically available on Flybase
(Graveley et al.) permit a comprehensive analysis of developmental expression of the
E(spl) gene during normal embryogenesis. Transcript levels of E(spl)mδ, E(spl)mγ, and
E(spl)m7 show a similar profile as Notch, which shows a peak of expression at 6-8 hours
of development after egg laying (Fig. 2-7). In contrast, E(spl)m3 shows peak expression
discernibly later, peaking at 8-10 hours AEL. The bell-shaped expression of the E(spl)
genes prompted us to test whether the effect of MeHg on increasing E(spl)mδ in embryos
was simply due to a developmental delay and shift in peak of gene expression versus an
ectopic induction of gene expression.

To achieve this we incubated batches of

developmentally staged embryos with or without MeHg for various treatment intervals,
and compared E(spl) expression via qRT-PCR. In untreated embryos the overall profile
of E(spl) expression showed the characteristic increase followed by a decrease over the
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course of embryogenesis. For E(spl)mδ, E(spl)mγ, and E(spl)m7 a peak of expression
between 6-8 hours after egg laying (AEL) was observed (Fig. 2-8). For E(spl)m3 this
peak was seen between 8-10 hours AEL. Notch expression showed a gradual decline over
the course of embryogenesis. With MeHg treatment, E(spl)mδ showed higher expression
at each time point after 6hr AEL compared to untreated embryos, with more than 2-fold
higher expression at the 8-10hr interval. Peak expression remained at the 6-8 hour AEL
interval with MeHg, indicating the developmental delay was not substantial at this time
point. Higher expression due to MeHg was not consistently observed for E(spl)mγ and
E(spl)m3, while E(spl)m7 did show modest increases at time points after 8hrs AEL with
MeHg treatment. Notch showed no consistent difference in expression due to MeHg
treatment over these developmental periods (Fig. 2-8). Hsp70 Bc, like E(spl)mδ, showed
increased expression due to MeHg treatment at every time point, confirming the access of
MeHg to embryonic tissues at all stages.
Observing that E(spl)mδ is upregulated in embryos after MeHg treatment we
investigated whether or not the MeHg effect was penetrant at later developmental stages.
First instar (L1) larvae were cultured on food containing 15µM MeHg and harvested for
qRT-PCR after reaching the wandering third instar (L3) stage. Previous analyses have
demonstrated that treatment of larvae with 15µM MeHg shows similar toxicity to 50µM
treatments of embryos (Rand et al., 2009; Mahapatra et al.). We then examined global
transcript levels of E(spl)s and Notch from whole larval extracts using qRT-PCR (Fig. 29). No change in expression due to MeHg in E(spl)mδ or any E(spl) in the larvae was
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observed. These data suggest that Drosophila tissues at later developmental stages than
the embryo are refractory to MeHg induced expression of E(spl).
To further test whether the effect of MeHg on E(spl)mδ expression is specific to
the embryo we tested E(spl) expression responses to MeHg in adult flies. Adult
Drosophila were cultured for three days on food containing various concentrations of
MeHg up to 100µM. RNA transcript levels in extracts prepared from isolated heads were
assayed by qRT-PCR. We opted to examine this tissue since Notch activity and E(spl)
expression is a strong determinant in neural tissues and the fly head is rich in brain tissue.
We determined that no consistent changes in E(spl)mδ, or any of the E(spl) genes
examined, were seen with MeHg treatments (data not shown). Altogether, the data from
larval and adult assays indicate that the global effect of MeHg on E(spl)mδ expression is
specific to embryos.
We next turned to examining the embryonic nervous system for phenotypes that
characteristically reflected MeHg insult to development.

Our previous studies have

identified several features in the embryo CNS and PNS that reflect compromised
development with MeHg exposure (Rand et al., 2009). Notably, neurite outgrowth of
CNS and PNS axons visualized in the lateral field of the late stage embryo has been seen
to be compromised (Rand et al., 2009). Using an antibody specific to the ISN, a bundle of
four axons of central motor neurons, we observed that these axons frequently failed to
develop properly in MeHg treated embryos (Fig. 2-10). This phenotype of MeHg
exposure presents as stunted or misguided ISNs in treated embryos (Fig. 2-10 D-F) and is
easily scored by the growth of axons relative to the position of elav-positive PNS neurons
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in the lateral field (Fig. 2-10 F). Interestingly, previous studies have identified a role for
Notch signaling in the appropriate projection of the ISN neuron (Giniger et al., 1993).
We therefore set out to test whether genetic manipulations of Notch in general,
and E(spl)mδ in particular, could mirror effects of MeHg on ISN development. We first
examined the effect of ubiquitous activation of Notch in post mitotic neurons by driving
expression of NICD under control of the pan-neural elav promoter using the GAL4/UAS
system (see methods). Ectopic expression of NICD in neurons could be detected with an
antibody to the NICD (Fig. 2-11 A-C) and by qRT-PCR. In general, the potent activity of
Notch was evident by an overall failure of a substantial number of embryos to develop to
late stages. Of those that were able to develop to late stage a common feature was seen in
a stunted outgrowth of the ISN (Fig. 2-11 D-F) akin to that seen with MeHg treatment.
As E(spl)mδ was the most consistent E(spl) responder to MeHg we next determined if
E(spl)mδ overexpression by the elav promoter could elicit an analogous MeHg-like ISN
phenotype. Despite unambiguous overexpression of E(spl)mδ in elav-GAL4>UASE(Spl)mδ embryos (as determined by qRT-PCR, as no E(spl)mδ antibodies are available)
no apparent phenotype in ISN development was observed (Fig. 2-11 G-I).

2.5: Discussion
In this study we have shown that MeHg causes an upregulation of E(spl)mδ in
Drosophila neural cells and, importantly, in embryos treated in vitro. This effect is
specific to MeHg and does not occur with inorganic mercury. This E(spl)mδ specific
response is starkly different from E(spl) activation profiles resulting from Notch receptor
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activation by the Delta ligand in the C6 neural cell line. MeHg elicits a characteristic
failure in ISN axon outgrowth that, to some extent, can be induced with neural
overexpression of Notch activity. However, targeted E(spl)mδ expression in neurons has
no effect on ISN development. A role for E(spl)mδ in mediating MeHg effects via nonneuronal cells remains to be investigated. Altogether, these data highlight a novel and
specific action for MeHg to target induced expression of a neurogenic signaling gene in
conjunction with elicited neural developmental phenotypes.
E(spl) genes, are basic helix-loop-helix (bHLH) transcriptional repressors. These
bHLH genes are the main effectors of Notch signaling in the nervous system, acting to
repress transcription of proneural genes and generally preventing a default neuronal
differentiation program from occurring. While various E(spl) genes have different
expression patterns there is enough redundancy in expression and function to make
discerning phenotypes difficult if only one E(spl) gene is perturbed. Nonetheless,
E(spl)mδ siRNA injection in Drosophila embryos results a neurogenic phenotype, albeit
with low frequency, consistent with a perturbation of Notch signaling (Nagel et al.,
2004). The low penetrance of phenotypic effects of E(spl)mδ perturbation predict that its
contribution to MeHg effects in the embryo will be subtle. It is thus not surprising that
genetic manipulation of E(spl)mδ exclusively in neurons is not sufficient to replicate the
MeHg-induced ISN phenotype. That genetic manipulation of the Notch pathway can
replicate this phenotype suggests that there may be a central role for the Notch pathway
in MeHg toxicity, potentially through the additive effects on E(spl)mδ and other E(spl)
genes. Further study of MeHg in this system may not only elucidate the mechanisms of
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MeHg toxicity but also reveal unique mechanisms for the differential expression of E(spl)
genes.
Our findings suggest that induction of E(spl)mδ by MeHg in vivo is restricted to
the embryonic stage. This observation is consistent with the notion that cellular defense
mechanisms (e.g. glutathione pathway) are not fully developed in early embryogenesis,
as compared with the differentiated larval and adult tissues.

This outcome grossly

mimics the preferential toxicity of MeHg for the fetus versus adult in higher organisms.
Alternatively, differences may stem from our method of administration of the MeHg,
which differ between our embryonic and larval/adult treatments: larvae and adult flies
consume MeHg with the food, and may be able to mitigate toxicity via the gut. In
contrast, embryos are soaked in MeHg medium allowing for more direct contact with
embryonic cells. Yet, at the doses used, larvae show similar lethality as embryos
(Mahapatra et al.). Assuming that embryo-specific induction of E(spl)mδ is not related to
the route of MeHg administration it may help elucidate the mechanism for the specific
neurodevelopmental toxicity in mice and humans.
In summary, we demonstrate that MeHg causes increased expression of E(spl)mδ
in vivo in Drosophila embryos. We also demonstrated that while E(spl)mδ transcript
upregulation correlates with MeHg neuronal phenotypes in embryos, E(spl)mδ
overexpression restricted to neurons is not sufficient to replicate this characteristic axon
outgrowth phenotype, pointing to a non-neuronal activity of E(spl)mδ in this toxicity
model. These findings set the stage for investigating novel mechanisms of MeHg toxicity
via non-canonical pathways of Notch signaling.
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2.7: Figures
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Figure 2 - 1. E(spl) gene expression in Delta ligand induced Notch signaling.
Organization of the Enhancer of split (E(spl)C) locus is diagramed and select genes analyzed in this study
are indicated with a “check mark”. Delta induced E(spl) expression was determined with a previously
described co-culture assay (Delwig and Rand, 2008). Briefly, S2 cells stably expressing the Notch ligand
Delta (Dl-S2 cells) or control S2 parent cells lacking the ligand were cultured as a monolayer then
stabilized through brief fixation. C6 cells, which express Notch endogenously, but not the Delta ligand,
were then co-cultured with either the fixed Dl-S2 cells or control S2 cells. E(spl) gene expression was
measured via qRT-PCR. Data represent the fold change in E(spl) expression in C6 cells due to Delta
exposure, Error bars indicate standard deviation. (n=6 (m2, m3, m7, mδ) to 12 (mβ and mγ) independent
experimental determinations, * = p<0.01 by Student’s t-test).
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Figure 2 - 2. Cell viability of Drosophila neural-derived cells after mercurial treatment.
Drosophila C6 cells were treated for three hours with various doses of MeHg or HgCl2. Viability was
determined with Calcein AM hydrolysis and ethidium homodimer permeability (see methods).
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Figure 2 - 3. E(spl) gene induction by mercurial treatment.
Drosophila C6 cells were treated for three hours with the indicated concentrations of MeHg or HgCl2.
E(spl) gene expression determined by qRT-PCR is expressed in fold change over control treatments. (n = 3
independent experiments; * = p<0.05, ** = p<0.01 by Student’s t-test).
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Figure 2 - 4. A schematic representation of in vitro dosing of Drosophila embryos with toxins.
Embryos collected from adults laying on grape-agar plates are dechorionated in dilute bleach. Embryos are
then placed in baskets designed to optimize air exposure while being immersed in a solution containing the
toxin of interest. After a period of developmental exposure, embryos can then be processed for RNA
isolation or for fixation, staining and, imaging.
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Figure 2 - 5. Dose response of E(spl)mδ in Drosophila embryos after MeHg treatment.
Drosophila embryos (2-4 hours after egg laying) were dechorionated and soaked in buffer containing
indicated concentration of MeHg for 16 hours. Gene expression for E(spl)mδ and the stress-response gene
Hsp70 Bc determined by qRT-PCR is expressed in fold change over 0 µM MeHg treatments. (n>300
pooled embryos per each treatment)
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Figure 2 - 6. E(spl) gene induction in Drosophila embryos after mercurial treatment.
Drosophila embryos 2-4 hours after egg laying were soaked overnight in buffer containing 50µM MeHg or
1mM HgCl2. Gene expression determined by qRT-PCR is expressed in fold change over control treatments.
Values are the mean (and SEM) of three independent treatments of embryo batches (n = 3 independent
experiments; * = p<0.05, ** = p<0.01 by Student’s t-test).
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Figure 2 - 7. Relative gene expression levels of select E(spl) genes and Notch during embryonic
development.
Relative gene expression levels determined through the Mod Encode project (Graveley et al.) were adapted
from FlyBase (Tweedie et al., 2009) and expressed graphically to allow comparison of peak expression
timing. E(spl)mδ, E(spl)mγ, and E(spl)m7 coincide with Notch peak expression at 6-8 hours after egg
laying. In contrast, E(spl)m3 expression occurs later peaking around 8-10 hours after egg laying.
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Figure 2 - 8. Response of E(spl) genes in Drosophila embryos after MeHg treatment over the course
of development.
Drosophila embryos were dechorionated and soaked in buffer containing 50µM MeHg for indicated
lengths of time. Gene expression determined by qRT-PCR is expressed in fold change over control
treatments for A) E(spl)mδ, B) E(spl)mγ, C) E(spl)m3, D) E(spl)m7, E) Notch, and F) HSP70 Bc. (Each
data point is derived from >300 pooled embryos from a treatment sampled at the indicated developmental
time points).
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Figure 2 - 9. E(spl) gene induction in Drosophila larvae after MeHg treatment.
Drosophila embryos were placed on standard cornmeal-molasses food containing 15µM MeHg or DMSO
vehicle control. Development was allowed to progress to the late third instar larvae stage. Larvae were then
homogenized, RNA extracted and gene expression determined by qRT-PCR, expressed in fold change over
control treatments. (Error bars indicate standard deviation of three experimental replicates. No significant
changes were found using Student’s t-test).
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Figure 2 - 10. MeHg treatment causes axonal disruption in embryos.
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A-C) Control embryos at developmental stage 14 were co-stained to show the intersegmental nerve
(ISN) and all neuronal nuclei using antibodies for FasII (A) and elav (B), respectively. D-F) Embryos
were treated with MeHg (50µM) and stained for FasII (D) and elav (E); disruption of ISN outgrowth is
indicated by arrowheads.
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Figure 2 - 11. Notch pathway activation in neurons disrupts nerve outgrowth in embryos that is not
induced with E(spl)mδ overexpression.
A-C) Embryos driving expression of the Notch intracellular domain (NICD), the active component of the
Notch receptor, under control of elav show notch immunoreactivity in neurons. D-F) elav> NICD embryos
stained for FasII (D) and elav (E) demonstrate stunted outgrowth of the ISN (arrow head). G-I) Embryos
with targeted expression of the E(spl)mδ gene in neurons stained for FasII (G) and elav (H) show normal
ISN outgrowth morphology.
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CHAPTER 3: THE EFFECTS OF METHYLMERCURY ON THE NOTCH
SIGNALING PATHWAY AND MOTOR NERVE FORMATION DURING
DROSOPHILA EMBRYONIC DEVELOPMENT
3.1: Abstract
Methylmercury (MeHg) is a ubiquitous environmental toxin. It is known that
MeHg has a potent impact on neural development, but the mechanisms for this
neurodevelopmental specificity are unknown. Previous work in our lab has shown that in
Drosophila embryos MeHg causes upregulation of a canonical Notch response gene
E(spl)mδ. In this study we hypothesize that this change in E(spl)mδ contributes to the
toxicity of MeHg in the embryo. We test this by exogenously overexpressing E(spl)mδ in
the embryo in an attempt to replicate a phenotype observed in the motor nerves following
MeHg treatment. Our experiments show that E(spl)mδ, but not the closely related gene
E(spl)mγ, can mimic the MeHg phenotype; however, the MeHg-like phenotype is only
elicited when E(spl)mδ is overexpressed in developing muscles and not neurons as we
originally predicted. Interestingly, we show that E(spl)mδ is endogenously expressed in
developing muscle. This work shows not only that E(spl)mδ plays an important role in
MeHg toxicity in the Drosophila embryo, but also that MeHg is capable of causing
developmental anomalies in the nervous system via non-autonomous effects on
supporting tissues.

3.2: Introduction
Methylmercury (MeHg) is an environmental contaminant that causes toxicity
during human neural development. Though large exposures can be prevented, low dose
MeHg exposure through the consumption of contaminated seafood is unavoidable for
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many populations. Contemporary epidemiological studies into the effects of this exposure
on children and fetuses have shown mixed results (Grandjean et al., 1995; Myers et al.,
1995; Rice, 2004). As such, it is important that we investigate the mechanisms of MeHg
toxicity so that we can formulate evidence-driven strategies to minimize the risk MeHg
poses to human health.
Previous work in our lab has shown that MeHg causes transcriptional
upregulation of the Enhancer of Split [E(spl)] complex gene E(spl)mδ in the embryonic
Drosophila model organism (Bland and Rand, 2006; Rand et al., 2008; Engel et al.,
2012). The E(spl) complex is a group of 13 canonical Notch response genes; E(spl)mδ is
one of several basic helix-loop-helix (bHLH) transcriptional repressors best known as
effectors of Notch signaling (Portin, 2002). Because Notch signaling is central in cell fate
determination in the neurectoderm we hypothesized that this induction of E(spl)mδ by
MeHg is important in MeHg toxicity and may contribute to its neurodevelopmental
specificity.
To investigate this possibility we sought a readily quantifiable neural phenotype
of MeHg toxicity in the embryos. Previous work in our lab had shown some deficits in
neural patterning and migration following MeHg treatment of embryos (Rand et al.,
2009). In this study we evaluate discernable defects in embryonic motor neuron axon
outgrowth that result from MeHg treatment. Motor nerve development in the Drosophila
embryo has been well characterized in the literature and follows a segmentally repeating
easily indentified pattern (Kaufmann et al., 1998; Murray et al., 1998; Landgraf et al.,
1999b; Sun et al., 2001; Sanchez-Soriano and Prokop, 2005). There are two major motor
nerves in the system, the dorsally projecting intersegmental nerve (ISN) and the laterally
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projecting segmental nerve (SN). The ISN is characterized by a single long fiber that
emerges from the ventral nerve cord and travels in a predominantly straight path to the
dorsal muscle field, synapsing with muscles along its path. The SN emerges from the
ventral nerve cord and immediately curves toward the lateral transverse (LT) muscle
group, forming a characteristic branch in order to innervate both the LT muscles and the
segmental border muscle (SBM). The pattern and development of muscles are similarly
well studied. All muscles in the Drosophila embryo begin with the selection of muscle
founder cells, which then fuse with a population of nearby fusion competent cells to form
multinucleated muscle fibers (Olson et al., 1995; Maqbool and Jagla, 2007; Tixier et al.,
2010). This recruitment and fusion by the muscle founder cells forms a segmentally
repeated muscle pattern. Among the field of several muscle groups the pattern of the four
LT muscles can be clearly observed as a cluster of parallel fibers.
In this study we maintain our hypothesis that E(spl)mδ plays an important role in
MeHg neurotoxicity. Staining for motor nerves in MeHg-treated embryos using
antibodies specific to the fasciculin II (FasII) adhesion molecule we observed a failure of
the ISN to project past lateral sensory neurons stained with a neural specific marker
(Elav) (Engel et al., 2012). We attempted to replicate this phenotype by overexpressing
E(spl)mδ in neurons, but did not observe any changes in ISN axon projection (Engel et
al., 2012)., We subsequently found E(spl)mδ is endogenously expressed in developing
muscle cells. By manipulating E(spl)mδ in developing muscle we observe a significant
impact on motor nerve outgrowth. Additionally, we demonstrate a specificity of E(spl)mδ
as a possible effector of MeHg toxicity by comparing it to the closely related E(spl) gene
E(spl)mγ which has no effect when ectopically expressed in developing muscle. Our
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findings show that MeHg is likely to influence nervous system development via gene
expression in supporting tissues and, furthermore, that E(spl)mδ plays a crucial role in
muscle, rather than neural, development.

3.3: Materials and Methods
Fly stocks and crosses:
Unless otherwise stated, fly stocks were maintained on standard cornmeal-yeastmolasses food at 25°C. Fly strains used include Canton S, elav-GAL4 (Bloomington
Drosophila Stock Center, #458), Mef2-gal4 (gift from Jim Vigoreaux, University of
Vermont), UAS-nuclearGFP (Bloomington Drosophila Stock Center, #4775), UASE(spl)mδ (Bloomington Drosophila Stock Center, #26677), UAS-E(spl)mδRNAi (Vienna
Drosophila RNAi Center, #13077), E(spl)mγ-lacZ (gift from Sarah Bray, University of
Cambridge (Cooper et al., 2000)), and UAS-E(spl)mγ (gift from Christos Delidakis,
University of Crete (Ligoxygakis et al., 1999)). Standard crosses were performed
between virgin female Gal4 driver lines and male UAS responder lines to generate F1
progeny to be tested.

Generation of E(spl)mδ-GFP reporter strain:
The 5kb upstream E(spl)mδ promoter region was amplified from genomic DNA
via PCR using Phusion DNA polymerase (New England Biolabs) to include restriction
endonuclease sites at each end (XbaI at 5’, KpnI at 3’) with the following primers:
Forward: gaTCTAGAgtaaattacagccacttgaag, Reverse: gaGGTACCgtagctgctggtgccgtac.
The product was then inserted into the Drosophila transformation vector pGreen H76

Pelican (Barolo et al., 2000) by cleaving both with XbaI and KpnI (New England
Biolabs) and ligating with T4 DNA ligase (New England Biolabs) (Fig. 3-2). Bacterial
transformation was performed with One Shot TOP10 chemically competent cells
(Invitrogen) according to manufacturer’s instructions. Bacteria were then plated on LB
agar plates containing ampicillin to select for transformants. Transformed colonies were
grown and the plasmid purified using a Qiagen maxiprep kit. The plasmid was verified to
ensure proper construction by DNA sequencing (Vermont Cancer Center DNA Analysis
Core Facility). Transgenic flies were created by P-element mediated germline
transformation (BestGene Inc).

Embryo mercury treatments:
Cages of adult flies were allowed to lay eggs on a grape agar plate with yeast
paste smeared on the center. Embryo collection occurred over a two hour laying period.
Embryos were then aged on the grape plates at 25°C for two hours. Embryos were
dechorionated using a standard protocol. Briefly, embryos were washed from the plate
using tap water and a brush into a nytex basket, then rinsed to remove yeast; baskets were
transferred to 50% bleach (~3.8% sodium hypochlorite) for three minutes, then rinsed in
tap water to remove bleach. Embryos were transferred to separate nytex baskets for each
treatment, which were in turn placed into petri dishes containing modified basic insect
medium with added mercury or DMSO control. These dishes were covered to prevent
evaporation and the embryos were allowed to incubate for 16-18 hours or various times
where indicated.
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Immunostaining:
Immunostaining was performed as previously described (Rand et al., 2009).
Treated embryos were fixed in 500 µL of a 50:50 mix of 8% paraformaldehyde in 0.1 M
PIPES, 2 mM EGTA, 1 mM MgSO4, pH 6.9 (PEM) with heptane by rocking for 25 min.
Vitelline membranes were subsequently removed by discarding the lower PEM layer and
adding 750 mL MeOH, then vortexing for 30 s. Settled embryos were collected, washed
and stored at -20C in methanol until staining. For immunostaining, embryos were
permeablized in phosphate buffered saline (PBS) with 1% BSA, 0.1% triton X-100
(PBT). Subsequent blocking, primary and secondary antibody incubations were done in
PBT with 5% each of donkey and goat serum. Primary antibodies used were: mouse antielav (9F8A9), rat anti-FasII (1D4) (Developmental Studies Hybridoma Bank, Univ. of
Iowa), rabbit anti-GFP (Torrey Pines Biolabs, Inc), rabbit anti-βgal (Chemicon
International), and rabbit anti-myosin (gift from Daniel Kiehart, Duke University).
Secondary antibodies used were: Alexa488-conjugated goat anti-rat, Alexa555conjugated goat anti-mouse, and Alexa555-conjugated goat anti-rabbit (Jackson
ImmunoResearch). Embryos were visualized by fluorescence microscopy on a Leitz
Orthoplan 2 microscope equipped with a Spot One digital camera and associated
acquisition software (MVI, Avon, MA). Phenotypes were scored per hemisegment
looking exclusively at abdominal segments 1-5. Images were assembled in Adobe
Photoshop, GIMP, and Microsoft PowerPoint.
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RNA extraction and quantitative PCR:
After mercury treatments, embryos were transferred with a paintbrush into
microcentrifuge tubes containing PBS supplemented with 0.1% Triton-X and 1% bovine
serum albumin (PBT). The PBT was removed with a pipette and replaced with Trizol
reagent (Invitrogen). Embryos were homogenized in Trizol and processed for RNA
isolation. RNA samples were treated with Turbo DNAse (Ambion) and reversed
transcribed using SSII reverse transcriptase (Invitrogen). RNA was subsequently
removed with RNAse H (USB). cDNA samples were assayed for gene expression via
qRT-PCR using SybrGreen dye (Bio-Rad). Data were normalized to the ribosomal
protein RP49 housekeeping gene and analyzed using the comparative Ct method (Livak
and Schmittgen, 2001). Primer sequences for E(spl)mδ and the RP49 control were taken
from (Rand et al., 2008). The sequences used for Sidestep were Forward:
GCGGCGGATATTAGGGCACGG and Reverse: CGGGTCGTTTAGGCTGGGCT. For
Beaten path Ia the sequences were Forward: CCGGTTCGTCCAGTTCCCGC and
Reverse: GCTTTGTTGCGCTGACCCGC.

3.4: Results
In a previous study we identified a phenotype of MeHg treatment in embryos in
the ISN (Engel et al., 2012). Additional observations identified a second phenotype of
MeHg treatment in embryonic motor nerves visualized with α-FasII antibodies; MeHg
treated embryos show a significant failure of branching in the SN (Fig. 3-1). This branch
failure was not observed to favor the development of one branch over the other;
development of the upper branch alone, lower branch alone, and stalling at the branch
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point were all observed with approximately equal frequency (data not shown). This SN
phenotype is more readily observed than the ISN phenotype, as it requires staining of
only the nerve itself and no additional marker. It is also easily quantified as individual
segments can be clearly identified as branching or failing to branch. We therefore utilized
this SN phenotype to elaborate MeHg effects in this study.
We have previously shown that overexpressing E(spl)mδ in neurons fails to cause
any changes in ISN outgrowth (Engel et al., 2012). We therefore analyzed endogenous
E(spl)mδ expression to discern where it might be acting in normal development.
Transgenic flies expressing an E(spl)mδ-GFP reporter construct show a similar pattern to
expression of GFP under control of the muscle-specific Mef2-gal4 driver, indicating that
endogenous expression of E(spl)mδ in embryos is in the muscle (Fig. 3-2).
We endeavored to determine whether we could replicate the effects of MeHg
treatment on SN branching by overexpression of E(spl)mδ in embryos. When
overexpressed in muscle, where it is endogenously expressed, using the Mef2-gal4 driver
E(spl)mδ causes a significant failure in SN branching (Fig. 3-3). Overexpression of
E(spl)mδ in neurons by Elav-gal4, however, did not cause increased SN branch failure
(Fig. 3-3). These data suggest that overexpression of E(spl)mδ in the substrata on which
the nerves elaborate, but not the nerves themselves, causes failure of proper axonal
outgrowth, mimicking that seen with MeHg treatment.
Seeing that E(spl)mδ overexpression in muscle caused a SN phenotype similar to
MeHg we wanted to determine whether either of these treatments grossly impacted
muscle development. We stained the muscles of MeHg treated, Mef2>mδ, and control
embryos using an α-myosin antibody and visualized them with immunofluorescence (Fig.
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3-4). To assess normal development we evaluated the morphology of the lateral
transverse muscles 1-4 (LT 1-4), known targets of the SN. Among control embryos only
1% of hemisegments observed showed a defect by the inability to identify each of the
four (Fig. 3-4 A). MeHg treated embryos showed disorganization of the muscle pattern,
with unidentifiable LT 1-4 in 15% of hemisegments (Fig. 3-4 B). Mef2>mδ embryos
showed even higher rates of muscle pattern failure, showing a disordered muscle
phenotype in 58% of hemisegments (Fig. 3-4 C). These data correlate with the SN
phenotype, which is more prevalent in Mef2>mδ embryos than those treated with MeHg
(Fig. 3-1, 3-3).
We wished to further investigate the relationship between the phenotypes we
observed in the SN and muscle. We co-stained MeHg treated and Mef2> mδ embryos for
FasII and myosin and looked at the coincidence of SN and muscle failure. Though
muscle phenotype was a significant predictor of SN phenotype it predicted only 84.4% of
the SN phenotype data correctly (binary logistic regression; n = 225; p < 0.001). In MeHg
treated embryos over 13% of the hemisegments quantified showed a SN phenotype but
no muscle phenotype, while nearly 12% showed a muscle phenotype but no SN
phenotype (Fig. 3-5). This indicates that factors other than gross muscle pattern play a
role in SN failure in our experiments.
It has been shown that interaction between Side expressed in the path of the
developing SN and Beat expressed in the axon growth cones plays an important role in
SN guidance during development (Siebert et al., 2009). We hypothesized that changes in
expression of these signaling molecules due to MeHg treatment or overexpression of
E(spl)mδ may contribute to the formation of the SN phenotype. To assay this we assessed
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expression levels of these signaling factors using qPCR on RNA extracted from whole
embryos treated with MeHg or overexpressing E(spl)mδ by Mef2-gal. This analysis
showed no significant change in expression of either gene in either treatment compared to
controls (Fig. 3-6).
In addition to looking at potential causes of the SN phenotype we observed after
MeHg treatment and E(spl)mδ upregulation in muscle we endeavored to determine
whether this effect was specific to E(spl)mδ or a common effect to other E(spl) genes.
We have previously shown that E(spl)mγ responds to MeHg treatment of Drosophila cell
lines (Rand et al., 2008). Though it does not respond to MeHg treatment in embryos,
E(spl)mγ is closely related to E(spl)mδ, and lies immediately downstream on the
chromosome (Wurmbach et al., 1999; Engel et al., 2012). In order to use E(spl)mγ as a
tool to look at the specificity of E(spl)mδ in the SN phenotype we first wanted to confirm
its endogenous expression pattern. mγ-lacZ flies stained for βgal and Elav show that
expression of E(spl)mγ largely restricted to neural cells in the embryo (Fig. 3-7).
In order to test whether E(spl)mγ could replicate the SN phenotype caused by
E(spl)mδ overexpression in muscle we drove expression of E(spl)mγ using the same
Mef2-gal4 driver line; no increase in the SN phenotype over controls was seen (Table 1).
Additionally, we attempted to drive expression of E(spl)mγ in neurons, where it is
endogenously expressed, to see what effect this might have on motor nerve development.
However, this cross proved lethal at early stages of embryonic development, preempting
the ability to assess effects on motor nerve phenotype.
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3.5: Discussion
We have shown that MeHg treatment in embryos causes failure of axon
outgrowth in the SN. When E(spl)mδ is overexpressed in muscle, where it is
endogenously expressed, but not the neurons themselves we see similar SN phenotypes.
In both MeHg treated and E(spl)mδ overexpressing embryos we see disruption of muscle
development, but we were unable to measure changes in expression of guidance cues
known to be expressed by the muscle. These phenotypes do not occur when another
E(spl), E(spl)mγ is overexpressed.
The combined results of these experiments lead us to a new model of how MeHg
interferes with embryonic development to impact the nervous system (Fig. 3-8). In this
model MeHg enters the cells of the embryo and through an as-of-yet unknown
mechanism causes the upregulation of E(spl)mδ. Though this upregulation may occur in
several tissue types it is in muscle progenitors that it has the greatest effect, causing
failure of the muscle to form normal patterns. E(spl)mδ overexpression in neurons does
not produce an observable phenotype, but perturbation of muscles by E(spl)mδ
upregulation influences the outgrowth of motor neurons. E(spl)mδ may also impact
muscle cells in other ways, such as disruption of the precise timing, but not overall
expression level, of Side that is necessary for motor nerve guidance.
This model proposes that MeHg-induced E(spl)mδ expression is not influencing
nervous system development by directly affecting neurons, but instead affecting
supporting cells required for the normal development of those neurons. Other labs have
found evidence that MeHg toxicity may be mediated by the effect of MeHg on glia
(Shanker et al., 2001). Further experiments on the effects of MeHg on neural
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development should analyze whether MeHg acts directly on neurons or rather on
supporting cells in the system studied.
The earliest and best studied role of the Notch pathway is in cell fate
determination of the neurectoderm. Like many highly conserved signaling pathways,
though, Notch is involved in many different processes. It has been shown that
components of the Notch pathway influence mesoderm development (Vasyutina et al.,
2007). Our work reinforces this literature by demonstrating a role for E(spl)mδ in the
formation of muscle patterning. Additional evidence for the important role of E(spl)mδ in
mesoderm development comes from experiments where we attempted to knockdown
E(spl)mδ expression using an RNAi strain driven by Mef2-gal4. This cross proved lethal
early in embryonic development [data not shown], which combined with the knowledge
that E(spl)mδ is endogenously expressed in the muscle and that overexpressing E(spl)mδ
causes disorganization of the muscle pattern indicates a critical role for E(spl)mδ in
mesoderm development.
Contrasting overexpression of E(spl)mδ with E(spl)mγ provides some additional
clues on the observed specificity in the response of E(spl)mδ to MeHg treatment. When
E(spl)mγ is overexpressed in tissues where it is found endogenously it proves lethal to the
embryo; when E(spl)mδ is overexpressed in a pattern mimicking its endogenous
expression embryos show a distinct phenotype, but develop to late embryonic stages and,
in fact, hatch into larvae at levels comparable to controls [data not shown]. One possible
explanation for this is that MeHg causes increased expression of both E(spl)mδ and
E(spl)mγ at variable levels in different embryos, and our observation that only E(spl)mδ
is upregulated in embryos following MeHg treatment is due to bias caused by the early
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lethality of embryos in which E(spl)mγ is upregulated in neurons. This seems unlikely,
however, as qPCR is a relatively sensitive measure of RNA transcript level, and E(spl)mγ
transcript will necessarily increase before the E(spl)mγ protein that presumably causes
lethality. A more interesting explanation for why E(spl)mδ and not E(spl)mγ is
upregulated is that because it is more lethal when overexpressed E(spl)mγ is more tightly
regulated by the embryo than E(spl)mδ. Evidence supporting this hypothesis could be
obtained by overexpressing other closely related E(spl) genes that do not respond to
MeHg treatment of embryos, such as E(spl)m3 or E(spl)m7, and measuring lethality in
the embryos; should these other E(spl) genes prove lethal when overexpressed it may
indicate that E(spl)mδ is uniquely benign among E(spl) genes, allowing it to be less
tightly regulated than other E(spl)s and thus more responsive to MeHg.

3.6: Conclusion
MeHg is characterized in the literature as a toxin that most potently impacts
neural development. In our Drosophila embryo model we observed effects of MeHg on
neural development, specifically in the outgrowth of motor axons. However, further
investigation into the observed motor nerve phenotype revealed that it is MeHg toxicity
affecting the muscles that causes the failure in nerves. Further experiments suggested by
this finding include investigating the precise interaction between muscle and nerve that is
impacted by MeHg treatment. This finding should also inform future research into MeHg
toxicity in general; where possible steps should be taken to analyze the effect of MeHg
on all tissues likely to impact the system being studied. Though MeHg toxicity in
mammals has been shown to impact neural development most severely, we should
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continue to investigate the impacts of MeHg on other tissues and the contributions that
might have to the observed neural phenotypes.
Our data continue to support an important role for E(spl)mδ in MeHg toxicity in
the Drosophila embryo, showing that E(spl)mδ specifically, and not the closely related
E(spl)mγ, can replicate a neural phenotype of MeHg treatment. We have also provided
evidence that E(spl)mδ is active primarily in the mesoderm during embryonic
development, rather than the neuroectoderm where Notch targets play their canonical
role. Further work investigating the molecular mechanisms by which MeHg effects
E(spl)mδ upregulation may provide valuable insight into MeHg toxicity, but also the
differential regulation of E(spl) genes in response to their endogenous activator, Notch.
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3.7: Tables and Figures

Table 3 - 1. Overexpression of E(spl)mγ does not cause branch failure in the SN.
Mef2-gal4 female flies were crossed with UAS-mγ males, producing offspring that overexpress E(spl)mγ
in mesoderm (Mef2>mγ). Mef2>mγ embryos at stage 14/15 were fixed and stained with αFasII and
compared to control embryos (Mef2>GFP). SN failure rate was the same in both groups. UAS-mγ was also
crossed with Elav-gal4, producing Elav>mγ overexpressing E(spl)mγ in neurons. This cross proved lethal,
and embryos did not develop beyond early stages. Each n is a single abdominal segment, A1-5, in which
the segmental nerve was seen to develop normally (Normal) or failed to branch (Failed). (n = 100 segments
per treatment)

Normal %

Failed %

Mef2>GFP (100)

93

7

Mef2>mγ (100)

93

7

Elav>mγ

Lethal
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Control
ISN

Normal

Failed axon

Control

(n = 300)

99.0%

1.0%

MeHg*

(n = 300)

81.0%

19.0%

SN

MeHg

Figure 3 - 1. MeHg treatment significantly alters SN branching.
Drosophila embryos 2-4 hours AEL were soaked overnight in buffer containing 50µM MeHg or DMSO
control. They were then fixed and stained with αFasII. Only embryos that developed to stage 14/15 were
used for quantification. Each n is a single abdominal segment, A1-5, in which the segmental nerve was
seen to develop normally (Normal) or failed to branch (Failed). Red arrows indicate SN branch failure. (n =
300 segments per treatment; * = p<0.0001 by Fisher’s exact test for the treatment indicated)

88

mδ-GFP reporter

Mef2>GFP (nuclear)

gal4

5kb mδ promoter

P
pUC8

I

P

I
eGFP

Mef2 driver

gal4

white

GFP (nuclear)
gal4
UAS

Figure 3 - 2. E(spl)mδ is endogenously expressed in mesodermal tissues in the Drosophila embryo.
Transgenic mδ-GFP reporter flies were created with the plasmid shown (see methods). Expression of the
green fluorescent protein (GFP) reporter in the transgenic flies shows a pattern similar to GFP expressed
under the control of a known mesodermal driver (Mef2) using the GAL4/UAS expression system.

89

Control

Normal

Failed axon

Mef2>GFP (n = 100)

Mef2>md

93.0%

7.0%

Mef2>mδ
δ*

(n = 200)

76.5%

23.5%

Elav-gal4

(n = 100)

94.0%

6.0%

Elav>mδ
δ

(n = 100)

94.0%

6.0%

Figure 3 - 3. Overexpression of E(spl)mδ in mesoderm significantly alters SN branching, replicating
the MeHg induced phenotype.
Mef2-gal4 female flies were crossed with UAS-mδ males, producing offspring that overexpress E(spl)mδ
in mesoderm (Mef2>mδ). Mef2>mδ embryos at stage 14/15 were fixed and stained with αFasII and
compared to control embryos (Mef2>GFP). UAS-mδ was also crossed with Elav-gal4, producing Elav>mδ
overexpressing E(spl)mδ in neurons. These were compared with the Elav-gal4 driver line. Each n is a single
abdominal segment, A1-5, in which the segmental nerve was seen to develop normally (Normal) or failed
to branch (Failed). Red arrows indicate SN branch failure. (n = 200 (Mef2>mδ) or 100 (Mef2>GFP,
Elav>mδ, Elav-gal4) segments per treatment; * = p<0.001 by Fisher’s exact test for the treatment indicated)
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A)

B)

LT 1-4

Control

50µM MeHg
D)

C)

Treatment:
CS 0 (n = 100)

Mef2>mδ
δ

% unidentifiable
muscle
1.0%

CS 50* (n = 100)

15.0%

Mef2>mδ
δ** (n = 100)

58.0%

Figure 3 - 4. MeHg treated and Mef2>mδ embryos show a disorganized muscle pattern.
Drosophila embryos 2-4 hours AEL were soaked overnight in buffer containing 50µM MeHg or DMSO
control (50µM MeHg and Control). These were compared to similarly aged untreated embryos
overexpressing E(spl)mδ in muscles (Mef2>mδ). Embryos were fixed and stained with αmyosin. Only
embryos that developed to stage 14/15 were used for quantification. Each n is a single abdominal segment,
A1-5, in which the lateral transverse muscles 1-4 were observed to determine if they had developed
sufficiently to be identifiable or were so disorganized as to be unidentifiable. Red arrows indicate
unidentifiable muscles. (n = 100 segments per treatment; * = p<0.001 by Fisher’s exact test for the
treatment indicated, ** = p<0.0001 by Fisher’s exact test for the treatment indicated)
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LT 1-4

LT 1-4

SN Branch

SN Branch

SN Phenotype:

-

-

+

+

Muscle Phenotype:

-

+

-

+

% in MeHg Treated
Embryos

69.7%

11.8%

13.2%

5.3%

Figure 3 - 5. SN and muscle phenotypes do not always co-occur.
Drosophila embryos 2-4 hours AEL were soaked overnight in buffer containing 50µM MeHg or DMSO
control. They were then fixed and stained with αFasII (red) and αmyosin (green). Only embryos that
developed to stage 14/15 are shown. Images were obtained from either MeHg treated or control embryos
and show that each combination of SN and muscle phenotypes occurred. MeHg treated embryos were
scored by a blinded scorer to record the presence of SN and/or muscle phenotypes for each abdominal
hemisegment, A1-5. Data show the percentage of scored hemisegments showing each phenotype
combination. (n = 75)
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Fold Change over Ctrl

425
4.5
4
3.5
3
2.5
2
1.5
1
0.5
0

50µM MeHg
mef2>md
δ

md

Side

Beat

Figure 3 - 6. Expression of known guidance cues is not altered by MeHg treatment or E(spl)mδ
overexpression.
RNA was harvested from groups of whole Drosophila embryos treated with 50µM MeHg and compared to
DMSO treated controls or overexpressing E(spl)mδ in muscles (Mef2>mδ) and compared to Mef2>GFP
embryos. Data shown are the fold induction of gene expression over appropriate controls for the treated
embryos, normalized to the unresponsive RP49 housekeeping gene.
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αβgal

αElav

composite

Figure 3 - 7. E(spl)mγ is expressed in the nervous system.
Embryos from an E(spl)mγ-lacZ fly strain were double stained for βgal (red), which should express where
E(spl)mγ is, and Elav (green), which is expressed in neurons.
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A)
MeHg

Factor
X
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B)
MeHg
Factor
X
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MeHg

mδ

Muscle
Progenitor

Factor
X

mγ

Neural
Progenitor

↑ mδ

↑ mδ

MeHg
MeHg

altered
development
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development

Figure 3 - 8. Working model of MeHg toxicity in Drosophila embryos.
Our current model for how MeHg affects Drosophila embryos to produce phenotypes in motor nerves.
A) MeHg enters cells in the embryo and binds to an unknown factor, X. B) The MeHg-Factor X
complex causes upregulation of E(spl)mδ, but is unable to cause upregulation of E(spl)mγ or other
E(spl) genes. C) In neurons this upregulation does not cause pathological changes, but in muscles
overexpression of E(spl)mδ causes failures that lead to improper/incomplete development. These
changes in muscle ultimately lead to an inability of motor axons, which normally receive important
guidance cues from the muscles, to properly follow their normal path.
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CHAPTER 4: SUMMARY AND CONCLUSIONS
MeHg is a potent environmental neurotoxin that shows particular toxicity during
neural development. Exposure to low doses of MeHg through fish and other seafood has
shown variability in effects on fetuses and children in a number of population studies,
inconsistently resulting in subtle behavioral and developmental deficits (Rice, 2004). Due
to the importance of seafood in the diet of many peoples and the near ubiquitous
contamination by MeHg, exposure to this toxin is inevitable. It is therefore crucial to
improve our understanding of the mechanisms involved in MeHg toxicity, so that we
might find ways to advise the public on ways to avoid any adverse effects of MeHg
exposure.
The studies in this dissertation advance the understanding of MeHg toxicity
primarily through dissecting its interaction with the neurogenic Notch signaling pathway.
The Notch pathway is known to be involved with development and differentiation of
many tissues, but plays its most prominent role in neural development (Portin, 2002). It
has been previously shown that MeHg treatment in neural-derived Drosophila cell lines
causes upregulation of the gene E(spl)mδ, a canonical Notch target, independent of Notch
receptor protein itself (Rand et al., 2008). Because the Notch pathway is so highly
involved in development of the nervous system I hypothesized that this change in
E(spl)mδ expression plays an important role in the neurodevelopmental specificity of
MeHg toxicity, and as such plays a role in MeHg toxicity in general.
Data from my studies show that MeHg treatment in vivo in embryos causes the
same characteristic upregulation of E(spl)mδ as it does in cultured cell lines. This is
crucial to establishing that the upregulation of E(spl)mδ observed in cells is not an artifact
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of the system being studied, and is not mitigated by the resilience of a whole organism.
My findings also show that this effect on E(spl)mδ is specific to MeHg, and can not be
replicated by the inorganic mercurial HgCl2 at doses showing similar toxicity.
Establishing the specificity of MeHg to induce this effect is crucial in showing it is not a
more generic response to stress or toxicity, which would indicate E(spl)mδ does not play
a role in defining the neurodevelopmental specificity of MeHg. Further, my studies
establish that this effect of MeHg on E(spl)mδ is not due to overall developmental delay
in the embryos. Though gross developmental delay is a plausible mechanism for MeHg to
cause toxicity it would have indicated that E(spl)mδ was simply a read-out of MeHg
exposure, and not an important effector of MeHg toxicity. (Engel et al., 2012)
Though my experiments provide evidence for a specific upregulation of E(spl)mδ
by MeHg, they do not indicate the mechanism that causes this effect. In my working
model of MeHg toxicity I suggest that this upregulation is caused by binding of MeHg to
an unidentified factor, X, with the MeHg/X complex driving expression of E(spl)mδ. I
believe that Factor X belongs to one of two classes of proteins, traditional transcription
factors or epigenetic regulators. If X is a traditional transcription factor it would have to
be one that binds the promoter of E(spl)mδ but not other E(spl) genes, as the other E(spl)s
are not upregulated by MeHg treatment in vivo. One plausible mechanism is that binding
of MeHg might alter the activity of the factor X, either in preventing normal activity of a
repressor or stimulating binding of an enhancer. A more thorough analysis of regulators
of E(spl) gene transcription might then reveal the identity of X. Factor X might also be an
epigenetic regulator of gene expression, such as a histone or histone deacetylase. If this is
the case then binding of MeHg may prevent normal function of the protein, ultimately
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affecting access of the regulatory sequences controlling expression of E(spl)mδ. As in the
case of X being a traditional transcription factor if X is an epigenetic regulator it will
necessarily interact with E(spl)mδ but not other E(spl) genes. As such identification of X
could be accomplished using techniques such as chromatin immunoprecipitation and
comparing the factors that associate with different E(spl)s to identify one that interacts
only with E(spl)mδ.
After establishing that E(spl)mδ is affected by MeHg in vivo I sought to identify
an appropriate phenotype of MeHg neural toxicity to determine whether E(spl)mδ is
involved. Utilizing immunofluorescence and referring to the abundant literature on
Drosophila development I identified phenotypes of MeHg treatment in the outgrowth and
pathfinding of motor nerves in the embryo. This finding provided an accessible model of
MeHg neural toxicity, which I probed to determine if genetic manipulation of E(spl)mδ
replicates MeHg-induced phenotypes. Unexpectedly, driving expression of E(spl)mδ in
neurons showed no discernable phenotype. I was then guided by the endogenous
expression of E(spl)mδ, which showed expression localized to muscle during embryonic
development. Overexpression of E(spl)mδ in muscle does cause a MeHg-like phenotype
in motor nerve pathfinding. This finding was criticial, as it provides strong evidence for
an important role of E(spl)mδ in MeHg toxicity; it also implies that the effects of MeHg
in the system studied are not due to direct toxicity in neurons but instead due to effects on
the substrate and targets for axon pathfinding.
By visualizing the muscles I was able to discern that both MeHg treatment and
E(spl)mδ overexpression cause gross developmental anomalies in muscle patterning. This
finding further supports the evidence indicating the phenotype I observed is due to
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toxicity in the muscle rather than neurons. Further experiments looking at the cooccurrence of the nerve and muscle phenotypes implicated factors beyond the gross
alterations in muscle pattern are impacting the success or failure of neural development.
Though I attempted to elucidate changes in signaling molecules known to impact motor
nerve pathfinding I was unable to observe any.
My experiments were unable to fully elucidate the mechanism by which E(spl)mδ
overexpression in the muscle was able to cause failure of SN outgrowth. There are
several possible mechanisms by which this may occur. First, the position of the muscles
may be compromised; if the muscles are not in the correct position the nerve might not be
able to find its target and thus stall. This could happen if the muscles are even subtly
misplaced, such that I could not discern a muscle phenotype but the nerve still failed to
branch. Failure of the muscles to occupy their proper position could also cause them to
directly block the normal path of the axon, preventing it from growing normally. The
other likely explanation for alteration of gene expression in muscles impacting nerve
development is an alteration in cell-to-cell signaling. This could occur because of a
failure of the normal attractive cues to be expressed. While I saw no global changes in
Sidestep expression in Mef2>mδ embryos there might be alteration in the tight
temporospatial regulation of the signal, which is crucial to the appropriate development
of the motor nerves (Siebert et al., 2009). More sensitive analysis of Sidestep expression,
perhaps using sidestep specific antibodies, would be necessary to determine exactly how
E(spl)mδ overexpression alters sidestep expression. Alternatively, induced expression of
E(spl)mδ in muscles could also cause inappropriate expression of a repulsive cue. This
would cause failure of motor nerve outgrowth just as surely as lack of attractive cues, and
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could be assayed simply in a first pass approach using qPCR as I have done here for Side
and Beat.
In this dissertation I also performed experiments to assess E(spl)mδ specificity in
its ability to induce the changes in muscle and motor nerve phenotype. Using a parallel
approach I investigated E(spl)mγ activity and found that overexpression in muscle does
not replicate the phenotypes seen with MeHg or E(spl)mδ. This indicates that E(spl)mδ is
unique among E(spl)s in its ability to impact muscle development, and contributes to the
literature showing that E(spl) genes act in discrete tissues during development (Jennings
et al., 1999).
The findings of this work suggest further experiments that would address the
impact of MeHg on human health. There has already been some study of the effect of
MeHg on the Notch pathway in rat neural stem cells, but given my findings on the
important role E(spl)mδ plays in Drosophila it will be worthwhile to more carefully study
the impact of MeHg on E(spl) homologues, the HES genes, in mammals (Jarriault et al.,
1998; Tamm et al., 2008). My studies show that only one E(spl) gene responds to MeHg
consistently in the Drosophila embryo. As such it will be important to look at each HES
gene individually to assess MeHg response. Should one or more HES genes prove to be
responsive to MeHg experiments that replicate my approach in Drosophila would be
appropriate; a neural phenotype of MeHg treatment could be identified in a mouse
embryo and steps taken to attempt to reproduce the phenotype using genetic
manipulations of HES genes. An additional line of inquiry applicable to human health
suggested by my results is looking at non-neural contributions to apparently neural
phenotypes of MeHg toxicity. Some work already suggests a role for glia in MeHg
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toxicity in mammals (Castoldi et al., 2001; Aschner et al., 2007; do Nascimento et al.,
2008). My work supports looking deeper into this connection and investigating the role of
other tissues, such as the circulatory system, that may interact non-autonomously to
potentiate MeHg neural toxicity.
The knowledge gained from my experiments reinforces the link between MeHg
toxicity and the Notch signaling pathway. Moreover, this work suggests several new
avenues of study that will continue to refine our understanding of MeHg. With further
experiments we may be able to make more accurate assessment of the susceptibility or
tolerance of a developing organism to MeHg, which will eventually inform
recommendations on seafood intake and lead to ways to ameliorate MeHg toxicity,
thereby reducing the threat of this global toxin.
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